Mark Francis Berry, MD

4.9/5

Biography

Dr. Berry joined the Division of Thoracic Surgery at Stanford in August 2014. He came to Stanford from Duke University, where he had most recently served as Associate Professor. He received his medical degree at the University of Pennsylvania School of Medicine after receiving bachelors and masters degrees in Electrical Engineering at the University of Pennsylvania. He completed his residency in Cardiothoracic Surgery at Duke University Medical Center after performing a residency in General Surgery at the Hospital of the University of Pennsylvania. His Cardiothoracic Surgical training included a year dedicated to Minimally Invasive General Thoracic Surgery, a period that also included an American Association for Thoracic Surgery sponsored Traveling Fellowship at the University of Pittsburgh.

Dr. Berry practices all aspects of thoracic surgery, including procedures for benign and malignant conditions of the lung, esophagus, and mediastinum. He has a particular interest in minimally invasive techniques, and has extensive experience in treating thoracic surgical conditions using video-assisted thoracoscopic surgical (VATS), laparoscopic, robotic, endoscopic, and bronchoscopic approaches. He serves as the co-Director of the Stanford Minimally Invasive Thoracic Surgery Center (SMITS), and has both directed and taught in several minimally invasive thoracic surgery courses.

Dr. Berry also has a Masters of Health Sciences in Clinical Research from Duke University. His clinical research activities mirror his clinical interests and activities in optimizing short-term and long-term outcomes of patients with thoracic surgical conditions. He has more than 150 peer-reviewed publications, most of which are related to both the use of minimally invasive thoracic surgical techniques as well as evaluating outcomes after treatment of thoracic malignancies. His clinical practice and his research both focus on choosing the most appropriate treatment and approach for patients based on the individual characteristics of the patient and their disease process.

View Full Biography

Professional Summary

Education & Certifications

Board Certification: American Board of Thoracic Surgery, Thoracic and Cardiac Surgery (2010)
Residency: Duke University Cardiothoracic Residency (2009) NC
Residency: University of Pennsylvania Surgery Residency PA
- Medical Education: Perelman School of Medicine University of Pennsylvania (1999) PA
- Board Certification: American Board of Surgery, General Surgery (2007)
- MHS, Duke University, Clinical Research (2012)
- MD, University of Pennsylvania, Medicine (1999)
- Post Bac, University of Pennsylvania, Pre-Health (1994)
- MSE, University of Pennsylvania, Electrical Engineering (1993)
- B Eng, University of Pennsylvania, Electrical Engineering (1990)

View More Education & Certifications

Honors & Awards

Member, Alpha Omega Alpha
Member, Eta Kappa Nu National Electrical Engineering Honor Society
Member, Pi Mu Epsilon National Math Honor Society
- Member, Tau Beta Pi National Engineering Honor Society

View More Honors & Awards

Publications

Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.
Jayasankar, V., Woo, Y. J., Bish, L. T., Pirolli, T. J., Chatterjee, S., Berry, M. F., … Sweeney, H. L. (2003). Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation, 108, II230–6.
Repair of acute type A aortic dissection associated with temporal arteritis
Berry, M. F., & Woo, Y. J. (2003). Repair of acute type A aortic dissection associated with temporal arteritis. ANNALS OF THORACIC SURGERY, 76(5), 1717–1718.
Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy
Jayasankar, V., Pirolli, T. J., Bish, L. T., Berry, M. F., Burdick, J., Grand, T., & Woo, Y. J. (2004). Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 36(4), 531–538.
- Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia
  Woo, Y. J., Taylor, M. D., Cohen, J. E., Jayasankar, V., Bish, L. T., Burdick, J., … Grand, T. (2004). Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 127(5), 1262–1269.
- Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function
  Jayasankar, V., Bish, L. T., Pirolli, T. J., Berry, M. F., Burdick, J., & Woo, Y. J. (2004). Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function. ANNALS OF THORACIC SURGERY, 77(6), 2122–2129.
- Apelin has in vivo inotropic effects on normal and failing hearts
  Berry, M. F., Pirolli, T. J., Jayasankar, V., Burdick, J., Morine, K. J., Gardner, T. J., & Woo, Y. J. (2004). Apelin has in vivo inotropic effects on normal and failing hearts. CIRCULATION, 110(11), II187–II193.
- Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy
  Jayasankar, V., Woo, Y. J., Bish, L. T., Pirolli, T. J., Berry, M. F., Burdick, J., … Sweeney, H. L. (2004). Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy. CIRCULATION, 110(11), II180–II186.
- Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling
  Berry, M. F., Woo, Y. J., Pirolli, T. J., Bish, L. T., Moise, M. A., Burdick, J. W., … Sweeney, H. L. (2004). Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 23(9), 1061–1068.
- Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure
  Berry, M. F., Pirolli, T. J., Jayasankar, V., Morine, K. J., Moise, M. A., Fisher, O., … Woo, Y. J. (2004). Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 128(6), 866–875.
- Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump coronary bypass.
  Taylor, M. D., Grand, T. J., Cohen, J. E., Hsu, V., Liao, G. P., Zentko, S., … Woo, Y. J. (2005). Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump coronary bypass. Heart, Lung & Circulation, 14(1), 25–31.
- Induction of angiogenesis and inhibition of apoptosis by hepatocyt growth factor effectively treats postischemic heart failure
  Jayasankar, V., Woo, Y. J., Pirolli, T. J., Bish, L. T., Berry, M. F., Burdick, J., … Sweeney, H. L. (2005). Induction of angiogenesis and inhibition of apoptosis by hepatocyt growth factor effectively treats postischemic heart failure. JOURNAL OF CARDIAC SURGERY, 20(1), 93–101.
- Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy
  Woo, Y. J., Grand, T. J., Berry, M. F., Atluri, P., Moise, M. A., Hsu, V. M., … Sweeney, H. L. (2005). Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 130(2), 321–329.
- Neurological monitoring and off-pump surgery in a very high-risk stroke patient
  Berry, M. F., McGarvey, M. L., Zeng, L., & Woo, Y. J. (2005). Neurological monitoring and off-pump surgery in a very high-risk stroke patient. ANNALS OF THORACIC SURGERY, 80(6), 2372–2374.
- Creatine phosphate administration preserves myocardial function in a model of off-pump coronary revascularization
  Woo, Y. J., Grand, T. J., Zentko, S., Cohen, J. E., Hsu, V., Atluri, P., … Kolakowski, S. (2005). Creatine phosphate administration preserves myocardial function in a model of off-pump coronary revascularization. JOURNAL OF CARDIOVASCULAR SURGERY, 46(3), 297–303.
- Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction.
  Cohen, J. E., Atluri, P., Taylor, M. D., Grand, T. J., Liao, G. P., Panlilio, C. M., … Woo, Y. J. (2006). Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction. Heart, Lung & Circulation, 15(2), 119–123.
- Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance
  Berry, M. F., Engler, A. J., Woo, Y. J., Pirolli, T. J., Bish, L. T., Jayasankar, V., … Sweeney, H. L. (2006). Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 290(6), H2196–H2203.
- Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy.
  Atluri, P., Liao, G. P., Panlilio, C. M., Hsu, V. M., Leskowitz, M. J., Morine, K. J., … Woo, Y. J. (2006). Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy. Annals of Thoracic Surgery, 81(5), 1728–1736.
- Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy
  Kolakowski, S., Berry, M. F., Atluri, P., Grand, T., Fisher, O., Moise, A., … Woo, Y. J. (2006). Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy. JOURNAL OF CARDIAC SURGERY, 21(6), 559–564.
- Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression
  Atluri, P., Morine, K. J., Liao, G. P., Panlilio, C. M., Berry, M. F., Hsu, V. M., … Woo, Y. J. (2007). Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. CELLULAR & MOLECULAR BIOLOGY LETTERS, 12(1), 127–38.
- Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1 alpha angiogenic therapy for acute myocardial infarction in a murine model
  Hiesinger, W., Brukman, M. J., McCormick, R. C., Fitzpatrick, J. R., Frederick, J. R., Yang, E. C., … Woo, Y. J. (2012). Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1 alpha angiogenic therapy for acute myocardial infarction in a murine model. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 143(4), 962–66.
- Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure
  Jayasankar, V., Woo, Y. J., Bish, L. T., Pirolli, T. J., Chatterjee, S., Berry, M. F., … Sweeney, H. L. (2003). Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. CIRCULATION, 108(10), 230–236.
- Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy - Invited commentary
  Atluri, P., Liao, G. P., Panlilio, C. M., Hsu, V. M., Leskowitz, M. J., Morine, K. J., … Madsen, J. C. (2006). Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy - Invited commentary. ANNALS OF THORACIC SURGERY, 81(5), 1728–1737.
- Impact of Pretreatment Imaging on Survival of Esophagectomy After Induction Therapy for Esophageal Cancer: Who Should be Given the Benefit of the Doubt? : Esophagectomy Outcomes of Patients with Suspicious Metastatic Lesions.
  Erhunmwunsee, L., Englum, B. R., Onaitis, M. W., D'Amico, T. A., & Berry, M. F. (2015). Impact of Pretreatment Imaging on Survival of Esophagectomy After Induction Therapy for Esophageal Cancer: Who Should be Given the Benefit of the Doubt? : Esophagectomy Outcomes of Patients with Suspicious Metastatic Lesions. Annals of Surgical Oncology, 22(3), 1020–1025.
- Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients.
  Berry, M. F., Coleman, B. K., Curtis, L. H., Worni, M., D'Amico, T. A., & Akushevich, I. (2015). Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients. Annals of Surgical Oncology, 22(2), 642–648.
- Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer
  Speicher, P. J., Ganapathi, A. M., Englum, B. R., Hartwig, M. G., Onaitis, M. W., D'Amico, T. A., & Berry, M. F. (2014). Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer. JOURNAL OF THORACIC ONCOLOGY, 9(8), 1195–1201.
- Thoracoscopic Left Upper Lobectomy in Patients With Internal Mammary Artery Coronary Bypass Grafts.
  Shah, A. A., Worni, M., Onaitis, M. W., Balderson, S. S., Harpole, D. H., D'Amico, T. A., & Berry, M. F. (2014). Thoracoscopic Left Upper Lobectomy in Patients With Internal Mammary Artery Coronary Bypass Grafts. The Annals of Thoracic Surgery.
- Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer.
  Speicher, P. J., Wang, X., Englum, B. R., Ganapathi, A. M., Yerokun, B., Hartwig, M. G., … Berry, M. F. (2015). Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer. Diseases of the Esophagus , 28(8), 788–96.
- Management of T2N0 Esophageal Cancer Reply
  Berry, M. F., Martin, J. T., & D'Amico, T. A. (2013). Management of T2N0 Esophageal Cancer Reply. ANNALS OF THORACIC SURGERY, 96(5), 1911–1911.
- Pneumonectomy for Stage IIIA NSCLC: A Chance, Not a Calamity Reply
  Shah, A. A., D'Amico, T. A., & Berry, M. F. (2014). Pneumonectomy for Stage IIIA NSCLC: A Chance, Not a Calamity Reply. ANNALS OF THORACIC SURGERY, 97(1), 382–383.
- The Utility of Pulmonary Function Tests in Predicting Pulmonary Outcomes Following Destination Therapy Left Ventricular Assist Device Placement
  Schechter, M. A., Castleberry, A. W., Kuchibhatla, M., Patel, C. B., Blue, L. J., Rogers, J. G., … Milano, C. A. (2014). The Utility of Pulmonary Function Tests in Predicting Pulmonary Outcomes Following Destination Therapy Left Ventricular Assist Device Placement. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 33(4), S60–S60.
- Does Pneumonectomy Have a Role in the Treatment of Stage IIIA Non-Small Cell Lung Cancer?
  Shah, A. A., Worni, M., Kelsey, C. R., Onaitis, M. W., D'Amico, T. A., & Berry, M. F. (2013). Does Pneumonectomy Have a Role in the Treatment of Stage IIIA Non-Small Cell Lung Cancer? ANNALS OF THORACIC SURGERY, 95(5), 1700–1707.
- Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non-Small-Cell Lung Cancer
  Berry, M. F., Worni, M., Pietrobon, R., D'Amico, T. A., & Akushevich, I. (2013). Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non-Small-Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 8(6), 744–752.
- Treatment Modalities for T1N0 Esophageal Cancers A Comparative Analysis of Local Therapy Versus Surgical Resection
  Berry, M. F., Zeyer-Brunner, J., Castleberry, A. W., Martin, J. T., Gloor, B., Pietrobon, R., … Worni, M. (2013). Treatment Modalities for T1N0 Esophageal Cancers A Comparative Analysis of Local Therapy Versus Surgical Resection. JOURNAL OF THORACIC ONCOLOGY, 8(6), 796–802.
- Contraindications of video-assisted thoracoscopic surgical lobectomy and determinants of conversion to open
  Hanna, J. M., Berry, M. F., & D'Amico, T. A. (2013). Contraindications of video-assisted thoracoscopic surgical lobectomy and determinants of conversion to open. JOURNAL OF THORACIC DISEASE, 5, S182–S189.
- Sleeve Lobectomy for Non-Small Cell Lung Cancer With N1 Nodal Disease Does Not Compromise Survival
  Berry, M. F., Worni, M., Wang, X., Harpole, D. H., D'Amico, T. A., & Onaitis, M. W. (2014). Sleeve Lobectomy for Non-Small Cell Lung Cancer With N1 Nodal Disease Does Not Compromise Survival. ANNALS OF THORACIC SURGERY, 97(1), 230–235.
- Survival in the Elderly after Pneumonectomy for Early-Stage Non-Small Cell Lung Cancer: A Comparison with Nonoperative Management
  Speicher, P. J., Ganapathi, A. M., Englum, B. R., Onaitis, M. W., D'Amico, T. A., & Berry, M. F. (2014). Survival in the Elderly after Pneumonectomy for Early-Stage Non-Small Cell Lung Cancer: A Comparison with Nonoperative Management. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 218(3), 439–449.
- Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer
  Haney, J. C., Hanna, J. M., Berry, M. F., Harpole, D. H., D'Amico, T. A., Tong, B. C., & Onaitis, M. W. (2014). Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 147(4), 1164–1168.
- The impact of pulmonary hypertension on morbidity and mortality following major lung resection
  Wei, B., D'Amico, T., Samad, Z., Hasan, R., & Berry, M. F. (2014). The impact of pulmonary hypertension on morbidity and mortality following major lung resection. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 45(6), 1028–1033.
- Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis.
  Castleberry, A. W., Güller, U., Tarantino, I., Berry, M. F., Brügger, L., Warschkow, R., … Worni, M. (2014). Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis. Journal of Gastrointestinal Surgery , 18(6), 1194–1204.
- Surgical Management of Congenital Pulmonary Malformations After the First Decade of Life
  Wang, A., D'Amico, T. A., & Berry, M. F. (2014). Surgical Management of Congenital Pulmonary Malformations After the First Decade of Life. ANNALS OF THORACIC SURGERY, 97(6), 1933–1938.
- Sex differences in early outcomes after lung cancer resection: Analysis of the Society of Thoracic Surgeons General Thoracic Database
  Tong, B. C., Kosinski, A. S., Burfeind, W. R., Onaitis, M. W., Berry, M. F., Harpole, D. H., & D'Amico, T. A. (2014). Sex differences in early outcomes after lung cancer resection: Analysis of the Society of Thoracic Surgeons General Thoracic Database. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 148(1), 13–18.
- Esophageal cancer: staging system and guidelines for staging and treatment
  Berry, M. F. (2014). Esophageal cancer: staging system and guidelines for staging and treatment. JOURNAL OF THORACIC DISEASE, 6, S289–S297.
- Thoracoscopic Approach to Lobectomy for Lung Cancer Does Not Compromise Oncologic Efficacy
  Berry, M. F., D'Amico, T. A., Onaitis, M. W., & Kelsey, C. R. (2014). Thoracoscopic Approach to Lobectomy for Lung Cancer Does Not Compromise Oncologic Efficacy. ANNALS OF THORACIC SURGERY, 98(1), 197–202.
- Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008
  Worni, M., Castleberry, A. W., Gloor, B., Pietrobon, R., Haney, J. C., D'Amico, T. A., … Berry, M. F. (2014). Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. DISEASES OF THE ESOPHAGUS, 27(7), 662–669.
- Is radiation without surgery the adequate therapy for potentially resectable esophageal squamous cell carcinoma? An analysis using the Surveillance Epidemiology, and End Results Registry from 1998 to 2008
  Worni, M., Gloor, B., Pietrobon, R., D'Amico, T. A., Akushevich, I., & Berry, M. F. (2012). Is radiation without surgery the adequate therapy for potentially resectable esophageal squamous cell carcinoma? An analysis using the Surveillance Epidemiology, and End Results Registry from 1998 to 2008. Presented at the 99th Annual Congress of the Swiss-Society-of-Surgery, DAVOS,SWITZERLAND: WILEY-BLACKWELL.
- Outcomes after treatment of resectable, node-negative esophageal cancer: A risk-adjusted analysis of the Surveillance, Epidemiology, and End Results registry
  Martin, J. T., Worni, M., Zwischenberger, J. B., Pietrobon, R., D'Amico, T. A., & Berry, M. F. (2012). Outcomes after treatment of resectable, node-negative esophageal cancer: A risk-adjusted analysis of the Surveillance, Epidemiology, and End Results registry. JOURNAL OF CLINICAL ONCOLOGY, 30(15).
- Diabetes mellitus: A significant co-morbidity in the setting of lung cancer?
  Washington, I., Chino, J. P., Marks, L. B., D'Amico, T. A., Berry, M. F., Ready, N. E., … Kelsey, C. R. (2013). Diabetes mellitus: A significant co-morbidity in the setting of lung cancer? THORACIC CANCER, 4(2), 123–130.
- Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer
  Higgins, K. A., Chino, J. P., Ready, N., Onaitis, M. W., Berry, M. F., D'Amico, T. A., & Kelsey, C. R. (2011). Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 142(5), 1175–1179.
- Perioperative Management of Patients on Clopidogrel (Plavix) Undergoing Major Lung Resection
  Ceppa, D. P., Welsby, I. J., Wang, T. Y., Onaitis, M. W., Tong, B. C., Harpole, D. H., … Berry, M. F. (2011). Perioperative Management of Patients on Clopidogrel (Plavix) Undergoing Major Lung Resection. ANNALS OF THORACIC SURGERY, 92(6), 1971–1976.
- Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection(dagger)
  Berry, M. F., Onaitis, M. W., Tong, B. C., Balderson, S. S., Harpole, D. H., & D'Amico, T. A. (2012). Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection(dagger). EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 41(4), 888–892.
- Outcomes After Surgical Management of Synchronous Bilateral Primary Lung Cancers
  Shah, A. A., Barfield, M. E., Kelsey, C. R., Onaitis, M. W., Tong, B., Harpole, D., … Berry, M. F. (2012). Outcomes After Surgical Management of Synchronous Bilateral Primary Lung Cancers. ANNALS OF THORACIC SURGERY, 93(4), 1055–1060.
- Local Failure in Resected N1 Lung Cancer: Implications for Adjuvant Therapy
  Higgins, K. A., Chino, J. P., Berry, M., Ready, N., Boyd, J., Yoo, D. S., & Kelsey, C. R. (2012). Local Failure in Resected N1 Lung Cancer: Implications for Adjuvant Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(2), 727–733.
- Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer
  Shah, A. A., Berry, M. F., Tzao, C., Gandhi, M., Worni, M., Pietrobon, R., & D'Amico, T. A. (2012). Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer. ANNALS OF THORACIC SURGERY, 93(6), 1807–1812.
- Lymphovascular Invasion in Non-Small-Cell Lung Cancer Implications for Staging and Adjuvant Therapy
  Higgins, K. A., Chino, J. P., Ready, N., D'Amico, T. A., Berry, M. F., Sporn, T., … Kelsey, C. R. (2012). Lymphovascular Invasion in Non-Small-Cell Lung Cancer Implications for Staging and Adjuvant Therapy. JOURNAL OF THORACIC ONCOLOGY, 7(7), 1141–1147.
- Thoracoscopic Lobectomy Has Increasing Benefit in Patients With Poor Pulmonary Function A Society of Thoracic Surgeons Database Analysis
  Ceppa, D. K. P., Kosinski, A. S., Berry, M. F., Tong, B. C., Harpole, D. H., Mitchell, J. D., … Onaitis, M. W. (2012). Thoracoscopic Lobectomy Has Increasing Benefit in Patients With Poor Pulmonary Function A Society of Thoracic Surgeons Database Analysis. ANNALS OF SURGERY, 256(3), 487–493.
- Does Surgery Improve Outcomes for Esophageal Squamous Cell Carcinoma? An Analysis Using the Surveillance Epidemiology and End Results Registry from 1998 to 2008
  Worni, M., Martin, J., Gloor, B., Pietrobon, R., D'Amico, T. A., Akushevich, I., & Berry, M. F. (2012). Does Surgery Improve Outcomes for Esophageal Squamous Cell Carcinoma? An Analysis Using the Surveillance Epidemiology and End Results Registry from 1998 to 2008. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 215(5), 643–651.
- Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer
  Villamizar, N. R., Darrabie, M., Hanna, J., Onaitis, M. W., Tong, B. C., D'Amico, T. A., & Berry, M. F. (2013). Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 145(2), 514–521.
- The Role of Radiation Therapy in Resected T2 N0 Esophageal Cancer: A Population-Based Analysis
  Martin, J. T., Worni, M., Zwischenberger, J. B., Gloor, B., Pietrobon, R., D'Amico, T. A., & Berry, M. F. (2013). The Role of Radiation Therapy in Resected T2 N0 Esophageal Cancer: A Population-Based Analysis. ANNALS OF THORACIC SURGERY, 95(2), 453–458.
- PERSISTENT N2 DISEASE AFTER NEOADJUVANT CHEMOTHERAPY-NOW WHAT?
  Higgins, K. A., Ready, N. E., D'Amico, T. A., Onaitis, M. W., Crawford, J., Clough, R., … Kelsey, C. R. (2011). PERSISTENT N2 DISEASE AFTER NEOADJUVANT CHEMOTHERAPY-NOW WHAT? JOURNAL OF THORACIC ONCOLOGY, 6(6), S1572–S1572.
- INDUCTION CHEMORADIOTHERAPY IS NOT SUPERIOR TO INDUCTION CHEMOTHERAPY ALONE IN PATIENTS WITH STAGE IIIA(N2) NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
  Shah, A. A., Berry, M. F., Tzao, C., Rajgor, D., Pietrobon, R., & D'Amico, T. A. (2011). INDUCTION CHEMORADIOTHERAPY IS NOT SUPERIOR TO INDUCTION CHEMOTHERAPY ALONE IN PATIENTS WITH STAGE IIIA(N2) NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. JOURNAL OF THORACIC ONCOLOGY, 6(6), S1578–S1579.
- Incorporating Research into Thoracic Surgery Practice
  D'Amico, T. A., Tong, B. C., Berry, M. F., Burfeind, W. R., & Onaitis, M. W. (2011). Incorporating Research into Thoracic Surgery Practice. THORACIC SURGERY CLINICS, 21(3), 369-?
- Repair of large complex recurrent incisional hernias with retromuscular mesh and panniculectomy
  Berry, M. F., Paisley, S., Low, D. W., & Rosato, E. F. (2007). Repair of large complex recurrent incisional hernias with retromuscular mesh and panniculectomy. AMERICAN JOURNAL OF SURGERY, 194(2), 199–204.
- Giant Thoracic Liposarcoma Treated with Induction Chemotherapy Followed by Surgical Resection
  Berry, M. F., Sporn, T. A., Moore, J. O., & D'Amico, T. A. (2009). Giant Thoracic Liposarcoma Treated with Induction Chemotherapy Followed by Surgical Resection. JOURNAL OF THORACIC ONCOLOGY, 4(6), 768–769.
- Risk Factors for Morbidity After Lobectomy for Lung Cancer in Elderly Patients
  Berry, M. F., Hanna, J., Tong, B. C., Burfeind, W. R., Harpole, D. H., D'Amico, T. A., & Onaitis, M. W. (2009). Risk Factors for Morbidity After Lobectomy for Lung Cancer in Elderly Patients. ANNALS OF THORACIC SURGERY, 88(4), 1093–1099.
- Pulmonary Function Tests Do Not Predict Pulmonary Complications After Thoracoscopic Lobectomy
  Berry, M. F., Villamizar-Ortiz, N. R., Tong, B. C., Burfeind, W. R., Harpole, D. H., D'Amico, T. A., & Onaitis, M. W. (2010). Pulmonary Function Tests Do Not Predict Pulmonary Complications After Thoracoscopic Lobectomy. ANNALS OF THORACIC SURGERY, 89(4), 1044–1052.
- Cardiac Angiosarcoma Presenting With Right Coronary Artery Pseudoaneurysm
  Berry, M. F., Williams, M., Welsby, I., & Lin, S. (2010). Cardiac Angiosarcoma Presenting With Right Coronary Artery Pseudoaneurysm. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 24(4), 633–635.
- A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia
  Berry, M. F., Atkins, Z., Tong, B. C., Harpole, D. H., D'Amico, T. A., & Onaitis, M. W. (2010). A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 140(6), 1266–1271.
- A model for morbidity after lung resection in octogenarians
  Berry, M. F., Onaitis, M. W., Tong, B. C., Harpole, D. H., & D'Amico, T. A. (2011). A model for morbidity after lung resection in octogenarians. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 39(6), 989–994.
- Neovasculogenic therapy with granulocyte-monocyte colony stimulating factor and stromal cell derived factor-1 alpha augments perfusion, reverses ischemia and preserves cardiomyocyte viability in ischemic cardiomyopathy
  Atluri, P., Liao, G. P., Panlilio, C. M., Morine, K. J., Berry, M. F., Cohen, J. E., … Woo, Y. J. (2005). Neovasculogenic therapy with granulocyte-monocyte colony stimulating factor and stromal cell derived factor-1 alpha augments perfusion, reverses ischemia and preserves cardiomyocyte viability in ischemic cardiomyopathy. CIRCULATION, 112(17), U503–U503.
- Substrate compliance alters human mesenchymal stem cell morphology
  Engler, A. J., Berry, M., Sweeney, H. L., & Discher, D. E. (2004). Substrate compliance alters human mesenchymal stem cell morphology. Presented at the 44th Annual Meeting of the American-Society-for-Cell-Biology, WASHINGTON,DC: AMER SOC CELL BIOLOGY.
- Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy
  Kolakowski, S., Grand, T., Fisher, O., Berry, M., Moise, M. A., Cohen, J., … Woo, Y. J. (2004). Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy. CIRCULATION, 110(17), 398–398.
- Ischemic heart failure increases local concentrations of the endogenous inotrope apelin-13 and the APJ receptor
  Atluri, P., Morine, K. J., Liao, G., Panlilio, C., Berry, M. F., Hsu, V., … Woo, Y. J. (2005). Ischemic heart failure increases local concentrations of the endogenous inotrope apelin-13 and the APJ receptor. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 38(5), 850–850.
- Treatment with granulocyte monocyte colony stimulating factor and stromal cell derived factor-1alpha enhances endothelial progenitor cell mediated myocardial perfusion and viability in ischemic cardiomyopathy
  Atluri, T., Liao, G., Panlilio, C., Morine, K., Berry, M., Hsu, V., … Woo, Y. J. (2005). Treatment with granulocyte monocyte colony stimulating factor and stromal cell derived factor-1alpha enhances endothelial progenitor cell mediated myocardial perfusion and viability in ischemic cardiomyopathy. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 201(3), S44–S44.
- Hepatocyte growth factor treatment preserves post-infarction cardiac function
  Jayasankar, V., Berry, M. F., Chatterjee, S., Bish, L. T., Pirolli, T. J., Gardner, T. J., … Woo, Y. J. (2003). Hepatocyte growth factor treatment preserves post-infarction cardiac function. CIRCULATION, 107(19), E139–E139.
- Treatment of experimental heart failure with hepatocyte growth factor
  Jayasankar, V., Pirolli, T. J., Bish, L. T., Berry, M. F., Woo, J., Sweeney, H. L., & Gardner, T. J. (2003). Treatment of experimental heart failure with hepatocyte growth factor. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 41(6), 544A–544A.
- Local myocardial growth hormone overexpression limits left ventricular dysfunction and remodeling in experimental heart failure
  Jayasankar, V., Berry, M., Bish, L., Pirolli, T., Burdick, J., Gardner, T., & Woo, Y. J. (2003). Local myocardial growth hormone overexpression limits left ventricular dysfunction and remodeling in experimental heart failure. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 197(3), S26–S27.
- Ethyl pyruvate reduces free radical production and preserves cardiac function in a rat model of off-pump coronary bypass
  Taylor, M. D., Grand, T. J., Cohen, J. E., Hsu, V., Zentko, S., Berry, M. F., & Woo, J. (2003). Ethyl pyruvate reduces free radical production and preserves cardiac function in a rat model of off-pump coronary bypass. CIRCULATION, 108(17), 549–549.
- Stromal cell derived factor provides a novel angiogenic therapy for ischemic cardiomyopathy
  Woo, Y. J., Grand, T. J., Berry, M., Cohen, J., Hsu, V., Taylor, M., … Jayasankar, V. (2003). Stromal cell derived factor provides a novel angiogenic therapy for ischemic cardiomyopathy. CIRCULATION, 108(17), 621–622.
- Matrix metalloproteinase inhibition by gene transfer of TIMP-1 attenuates ventricular remodeling and preserves cardiac function in ischemic cardiomyopathy
  Jayasankar, V., Bish, L. T., Pirolli, T. J., Berry, M. F., Burdick, J., Bhalla, R. C., … Woo, Y. J. (2003). Matrix metalloproteinase inhibition by gene transfer of TIMP-1 attenuates ventricular remodeling and preserves cardiac function in ischemic cardiomyopathy. CIRCULATION, 108(17), P-P.
- Apelin has in vivo inotropic effects on normal and failing hearts
  Berry, M. F., Jayasankar, V., Pirolli, T. J., Burdick, J. W., Morine, K. J., Gardner, T. J., & Woo, Y. J. (2003). Apelin has in vivo inotropic effects on normal and failing hearts. CIRCULATION, 108(17), 550–550.
- Mesenchymal stem cell injection into acutely infarcted myocardium decreases fibrosis and apoptosis and significantly preserves ventricular function and geometry
  Berry, M. F., Jayasankar, V., Pirolli, T. J., Gardner, T. J., Sweeney, H. L., & Woo, Y. J. (2003). Mesenchymal stem cell injection into acutely infarcted myocardium decreases fibrosis and apoptosis and significantly preserves ventricular function and geometry. CIRCULATION, 108(17), 622–622.
- Matrix metalloproteinase inhibition by gene transfer of TIMP-1 attenuates ventricular remodeling and preserves cardiac function in ischemic cardiomyopathy
  Jayasankar, V., Bish, L. T., Pirolli, T. J., Berry, M. F., Burdick, J., Bhalla, R. C., … Woo, Y. J. (2003). Matrix metalloproteinase inhibition by gene transfer of TIMP-1 attenuates ventricular remodeling and preserves cardiac function in ischemic cardiomyopathy. CIRCULATION, 108(17), 366–366.
- GMCSF and SDF treatment induces neovasculogenesis in a mouse ischemic hindlimb model
  Moise, M. A., Berry, M., Grand, T., Fisher, O., Morris, L., Kolakowski, S., … Woo, Y. J. (2004). GMCSF and SDF treatment induces neovasculogenesis in a mouse ischemic hindlimb model. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 199(3), S105–S105.
- Dexon mesh splenorrhaphy for intraoperative splenic injuries
  Berry, M. F., Rosato, E. F., & Williams, N. N. (2003). Dexon mesh splenorrhaphy for intraoperative splenic injuries. AMERICAN SURGEON, 69(2), 176–180.
- Surgical management of pancreatic neuroendocrine tumors.
  Berry, M. F., Williams, N. N., Lee, J. H., Whittington, R., Canter, R. J., & Rosato, E. F. (2000). Surgical management of pancreatic neuroendocrine tumors. GASTROENTEROLOGY, 118(4), A1504–A1505.
- Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas
  Lee, J. H., Whittington, R., Williams, N. N., Berry, M. F., Vaughn, D. J., Haller, D. G., & Rosato, E. F. (2000). Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 47(4), 945–953.
- Complications of thoracoscopic pulmonary resection.
  Berry, M. F., & D'Amico, T. A. (2007). Complications of thoracoscopic pulmonary resection. Seminars in Thoracic and Cardiovascular Surgery, 19(4), 350–354.
- Incorporating research into thoracic surgery practice.
  D'Amico, T. A., Tong, B. C., Berry, M. F., Burfeind, W. R., & Onaitis, M. W. (2011). Incorporating research into thoracic surgery practice. Thoracic Surgery Clinics, 21(3), 369–377.
- Outcomes after Pneumonectomy for Benign Disease: The Impact of Urgent Resection
  Klapper, J., Hirji, S., Hartwig, M. G., D'Amico, T. A., Harpole, D. H., Onaitis, M. W., & Berry, M. F. (2014). Outcomes after Pneumonectomy for Benign Disease: The Impact of Urgent Resection. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 219(3), 518–524.
- Reply: To PMID 23063200.
  Berry, M. F., Martin, J. T., & D'Amico, T. A. (2013). Reply: To PMID 23063200. Annals of Thoracic Surgery, 96(5), 1911-?
- Reply: To PMID 23545195.
  Shah, A. A., D'Amico, T. A., & Berry, M. F. (2014). Reply: To PMID 23545195. Annals of Thoracic Surgery, 97(1), 382–383.
- Thoracoscopic Left Upper Lobectomy in Patients With Internal Mammary Artery Coronary Bypass Grafts
  Shah, A. A., Worni, M., Onaitis, M. W., Balderson, S. S., Harpole, D. H., D'Amico, T. A., & Berry, M. F. (2014). Thoracoscopic Left Upper Lobectomy in Patients With Internal Mammary Artery Coronary Bypass Grafts. ANNALS OF THORACIC SURGERY, 98(4), 1207–1213.
- Use of Amiodarone After Major Lung Resection
  Berry, M. F., D'Amico, T. A., & Onaitis, M. W. (2014). Use of Amiodarone After Major Lung Resection. ANNALS OF THORACIC SURGERY, 98(4), 1199–1206.
- The prognostic importance of the number of dissected lymph nodes after induction chemoradiotherapy for esophageal cancer.
  Hanna, J. M., Erhunmwunsee, L., Berry, M., D'Amico, T., & Onaitis, M. (2015). The prognostic importance of the number of dissected lymph nodes after induction chemoradiotherapy for esophageal cancer. Annals of Thoracic Surgery, 99(1), 265–269.
- Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma
  Speicher, P. J., Englum, B. R., Ganapathi, A. M., Mulvihill, M. S., Hartwig, M. G., Onaitis, M. W., … Berry, M. F. (2015). Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma. JOURNAL OF THORACIC ONCOLOGY, 10(1), 181–88.
- Hyperbaric oxygen therapy for treatment of neurologic sequela after atrioesophageal fistula.
  Hirji, S. A., Haney, J. C., Welsby, I., Lombard, F. W., & Berry, M. F. (2015). Hyperbaric oxygen therapy for treatment of neurologic sequela after atrioesophageal fistula. Annals of Thoracic Surgery, 99(2), 681–682.
- Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors.
  Nussbaum, D. P., Speicher, P. J., Gulack, B. C., Hartwig, M. G., Onaitis, M. W., D'Amico, T. A., & Berry, M. F. (2015). Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors. Annals of Thoracic Surgery, 99(2), 428–434.
- Causal Effects of Time-Dependent Treatments in Older Patients with Non-Small Cell Lung Cancer
  Akushevich, I., Arbeev, K., Kravchenko, J., & Berry, M. (2015). Causal Effects of Time-Dependent Treatments in Older Patients with Non-Small Cell Lung Cancer. PLOS ONE, 10(4).
- Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis
  Kravchenko, J., Berry, M., Arbeev, K., Lyerly, H. K., Yashin, A., & Akushevich, I. (2015). Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. LUNG CANCER, 88(1), 85–93.
- Outcomes after treatment of 17 378 patients with locally advanced (T3N0-2) non-small-cell lung cancer†.
  Speicher, P. J., Englum, B. R., Ganapathi, A. M., Onaitis, M. W., D'Amico, T. A., & Berry, M. F. (2015). Outcomes after treatment of 17 378 patients with locally advanced (T3N0-2) non-small-cell lung cancer†. European Journal of Cardio-Thoracic Surgery , 47(4), 636–641.
- Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy.
  Pepek, J. M., Marks, L. B., Berry, M. F., Ready, N. E., Gee, N. G., Coleman, R. E., … Kelsey, C. R. (2015). Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy. Practical Radiation Oncology, 5(2), 79–84.
- Pulmonary Artery Bleeding During Video-Assisted Thoracoscopic Surgery: Intraoperative Bleeding and Control.
  Berry, M. F. (2015). Pulmonary Artery Bleeding During Video-Assisted Thoracoscopic Surgery: Intraoperative Bleeding and Control. Thoracic Surgery Clinics, 25(3), 239–47.
- Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database
  Meyerhoff, R. R., Yang, C.-F. J., Speicher, P. J., Gulack, B. C., Hartwig, M. G., D'Amico, T. A., … Berry, M. F. (2015). Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. JOURNAL OF SURGICAL RESEARCH, 196(1), 23–32.
- Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment
  Yang, C.-F. J., Meyerhoff, R. R., Stephens, S. J., Singhapricha, T., Toomey, C. B., Anderson, K. L., … Berry, M. F. (2015). Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment. ANNALS OF THORACIC SURGERY, 99(6), 1914–20.
- Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?
  Speicher, P. J., Gu, L., Wang, X., Hartwig, M. G., D'Amico, T. A., & Berry, M. F. (2015). Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported? JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(6), 755–61.
- Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.
  Berry, M. F., Jeffrey Yang, C.-F., Hartwig, M. G., Tong, B. C., Harpole, D. H., D'Amico, T. A., & Onaitis, M. W. (2015). Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer. Annals of Thoracic Surgery, 100(1), 271–76.
- Adjuvant chemotherapy after resection of N1 non-small cell lung cancer: differential impact of new evidence on physician and patient decisions
  Coleman, B. K., Curtis, L. H., Onaitis, M. W., D'Amico, T. A., & Berry, M. F. (2015). Adjuvant chemotherapy after resection of N1 non-small cell lung cancer: differential impact of new evidence on physician and patient decisions. JOURNAL OF THORACIC DISEASE, 7(3), 243–251.
- Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer
  Berry, M. F., Yang, C.-F. J., Hartwig, M. G., Tong, B. C., Harpole, D. H., D'Amico, T. A., & Onaitis, M. W. (2015). Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer. ANNALS OF THORACIC SURGERY, 100(1), 271–77.
- The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer
  Gulack, B. C., Yang, C.-F. J., Speicher, P. J., Meza, J. M., Gu, L., Wang, X., … Berry, M. F. (2015). The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer. LUNG CANCER, 90(3), 554–60.
- Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer
  Speicher, P. J., Wang, X., Englum, B. R., Ganapathi, A. M., Yerokun, B., Hartwig, M. G., … Berry, M. F. (2015). Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer. DISEASES OF THE ESOPHAGUS, 28(8), 788–96.
- Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer
  Yang, C.-F. J., Gulack, B. C., Gu, L., Speicher, P. J., Wang, X., Harpole, D. H., … Hartwig, M. G. (2015). Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 150(6), 1484–92.
- Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States
  Speicher, P. J., Gu, L., Gulack, B. C., Wang, X., D'Amico, T. A., Hartwig, M. G., & Berry, M. F. (2016). Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States. CLINICAL LUNG CANCER, 17(1), 47–55.
- Troubleshooting thoracoscopic anterior mediastinal surgery: lessons learned from thoracoscopic lobectomy.
  Hirji, S. A., Balderson, S. S., Berry, M. F., & D'Amico, T. A. (2015). Troubleshooting thoracoscopic anterior mediastinal surgery: lessons learned from thoracoscopic lobectomy. Annals of Cardiothoracic Surgery, 4(6), 545–49.
- Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.
  Yang, C.-F. J., Chan, D. Y., Speicher, P. J., Gulack, B. C., Wang, X., Hartwig, M. G., … Harpole, D. H. (2016). Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer. Journal of Clinical Oncology , 34(10), 1057–64.
- Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer
  Javidfar, J., Speicher, P. J., Hartwig, M. G., D'Amico, T. A., & Berry, M. F. (2016). Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer. ANNALS OF THORACIC SURGERY, 101(3), 1060–67.
- Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base
  Yang, C.-F. J., Sun, Z., Speicher, P. J., Saud, S. M., Gulack, B. C., Hartwig, M. G., … Berry, M. F. (2016). Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base. ANNALS OF THORACIC SURGERY, 101(3), 1037–42.
- Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer(aEuro)
  Yang, C.-F. J., Adil, S. M., Anderson, K. L., Meyerhoff, R. R., Turley, R. S., Hartwig, M. G., … Berry, M. F. (2016). Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer(aEuro). EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 49(6), 1607–13.
- Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer(aEuro)
  Yang, C.-F. J., Meyerhoff, R. R., Mayne, N. R., Singhapricha, T., Toomey, C. B., Speicher, P. J., … Berry, M. F. (2016). Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer(aEuro). EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 49(6), 1615–23.
- Long-term outcomes after lobectomy for non small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis
  Yang, C.-F. J., Kumar, A., Gulack, B. C., Mulvihill, M. S., Hartwig, M. G., Wang, X., … Berry, M. F. (2016). Long-term outcomes after lobectomy for non small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 151(5), 1380–88.
- Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis.
  Yerokun, B. A., Sun, Z., Jeffrey Yang, C.-F., Gulack, B. C., Speicher, P. J., Adam, M. A., … Hartwig, M. G. (2016). Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis. Annals of Thoracic Surgery, 102(2), 416–23.
- Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.
  Speicher, P. J., Fitch, Z. W., Gulack, B. C., Yang, C.-F. J., Tong, B. C., Harpole, D. H., … Hartwig, M. G. (2016). Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer. Annals of Thoracic Surgery, 102(3), 884–94.
- Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients.
  Yang, C.-F. J., Mayne, N. R., Wang, H., Meyerhoff, R. R., Hirji, S., Tong, B. C., … Berry, M. (2016). Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients. Annals of Thoracic Surgery, 102(3), 962–70.
- Minimally invasive lobectomy for early stage non-small cell lung cancer-it can be done without sacrificing oncologic outcomes.
  Berry, M. F. (2016). Minimally invasive lobectomy for early stage non-small cell lung cancer-it can be done without sacrificing oncologic outcomes. Journal of Thoracic Disease, 8(8), E799–801.
- The Role of Induction Therapy for Esophageal Cancer.
  Berry, M. F. (2016). The Role of Induction Therapy for Esophageal Cancer. Thoracic Surgery Clinics, 26(3), 295–304.
- Invited Commentary.
  Berry, M. F. (2016). Invited Commentary. Annals of Thoracic Surgery, 102(4), 1130–31.
- Impact of Pretreatment Imaging on Survival of Esophagectomy After Induction Therapy for Esophageal Cancer: Who Should be Given the Benefit of the Doubt?
  Erhunmwunsee, L., Englum, B. R., Onaitis, M. W., D'Amico, T. A., & Berry, M. F. (2015). Impact of Pretreatment Imaging on Survival of Esophagectomy After Induction Therapy for Esophageal Cancer: Who Should be Given the Benefit of the Doubt? ANNALS OF SURGICAL ONCOLOGY, 22(3), 1020–25.
- Discrete Improvement in Racial Disparity in Survival among Patients with Stage IV Colorectal Cancer: a 21-Year Population-Based Analysis
  Castleberry, A. W., Gueller, U., Tarantino, I., Berry, M. F., Bruegger, L., Warschkow, R., … Worni, M. (2014). Discrete Improvement in Racial Disparity in Survival among Patients with Stage IV Colorectal Cancer: a 21-Year Population-Based Analysis. JOURNAL OF GASTROINTESTINAL SURGERY, 18(6), 1194–1204.
- Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients.
  Waldron, N. H., Dallas, T., Erhunmwunsee, L., Wang, T. Y., Berry, M. F., & Welsby, I. J. (2016). Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients. Journal of Thrombosis and Thrombolysis, -?
- Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.
  Yang, C.-F. J., Yan, B. W., Meyerhoff, R. R., Saud, S. M., Gulack, B. C., Speicher, P. J., … Berry, M. F. (2016). Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma. Clinical Lung Cancer, 17(5), 419–26.
- Video-assisted thoracoscopic diaphragm plication using a running suture technique is durable and effective.
  Demos, D. S., Berry, M. F., Backhus, L. M., & Shrager, J. B. (2016). Video-assisted thoracoscopic diaphragm plication using a running suture technique is durable and effective. Journal of Thoracic and Cardiovascular Surgery.
- in Patients With Short Tracheas.
  Cohn, S., Brodsky, J. B., & Berry, M. F. (2016). in Patients With Short Tracheas. Journal of Cardiothoracic and Vascular Anesthesia.
- Reply to D.A. Palma.
  Yang, C.-F. J., Chan, D. Y., D'Amico, T. A., Berry, M. F., & Harpole, D. H. (2016). Reply to D.A. Palma. Journal of Clinical Oncology , JCO2016702787-?
- Reply to T.-H. Wang et al.
  Yang, C.-F. J., Chan, D. Y., Wang, X., D'Amico, T. A., Harpole, D. H., & Berry, M. F. (2017). Reply to T.-H. Wang et al. Journal of Clinical Oncology , 35(1), 118–20.
- A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer
  Gulack, B. C., Yang, C.-F. J., Speicher, P. J., Yerokun, B. A., Tong, B. C., Onaitis, M. W., … Berry, M. F. (2016). A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer. ANNALS OF THORACIC SURGERY, 102(6), 1814–20.
- The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.
  Cox, M. L., Yang, C.-F. J., Speicher, P. J., Anderson, K. L., Fitch, Z. W., Gu, L., … Berry, M. F. (2017). The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients. Journal of Thoracic Oncology .
- Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.
  Speicher, P. J., Englum, B. R., Ganapathi, A. M., Wang, X., Hartwig, M. G., D'Amico, T. A., & Berry, M. F. (2017). Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. Annals of Surgery, 265(4), 743–49.
- The EZ-Blocker (R) in Patients With Short Tracheas
  Cohn, S., Brodsky, J. B., & Berry, M. F. (2017). The EZ-Blocker (R) in Patients With Short Tracheas. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 31(2), 631–32.
- Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients
  Waldron, N. H., Dallas, T., Erhunmwunsee, L., Wang, T. Y., Berry, M. F., & Welsby, I. J. (2017). Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 43(2), 194–202.
- Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.
  Yang, C.-F. J., Chan, D. Y., Speicher, P. J., Gulack, B. C., Tong, B. C., Hartwig, M. G., … Harpole, D. H. (2017). Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer. Annals of Thoracic Surgery, 103(6), 1767–72.
- A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
  Yerokun, B. A., Yang, C.-F. J., Gulack, B. C., Li, X., Mulvihill, M. S., Gu, L., … Hartwig, M. G. (2017). A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery.
- Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients.
  Erhunmwunsee, L., Gulack, B. C., Rushing, C., Niedzwiecki, D., Berry, M. F., & Hartwig, M. G. (2017). Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients. Annals of Thoracic Surgery.
- Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies.
  Yao, X. I., Wang, X., Speicher, P. J., Hwang, E. S., Cheng, P., Harpole, D. H., … Pang, H. H. (2017). Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies. Journal of the National Cancer Institute, 109(8).
- Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer.
  Yang, C.-F. J., Chan, D. Y., Shah, S. A., Yerokun, B. A., Wang, X. F., D'Amico, T. A., … Harpole, D. H. (2017). Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer. Annals of Surgery.
- Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.
  Anderson, K. L., Mulvihill, M. S., Yerokun, B. A., Speicher, P. J., D'Amico, T. A., Tong, B. C., … Hartwig, M. G. (2017). Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival. European Journal of Cardio-Thoracic Surgery .
- Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary?
  Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2018). Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary? The Journal of Thoracic and Cardiovascular Surgery.
- Thoracic Surgery Considerations in Obese Patients
  Liou, D. Z., & Berry, M. F. (2018). Thoracic Surgery Considerations in Obese Patients. THORACIC SURGERY CLINICS, 28(1), 27-+.
- A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.
  Yang, C.-F. J., Kumar, A., Klapper, J. A., Hartwig, M. G., Tong, B. C., Harpole, D. H., … D'Amico, T. A. (2017). A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer. Annals of Surgery.
- Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis
  Yang, C.-F. J., Gu, L., Shah, S. A., Yerokun, B. A., D'Amico, T. A., Hartwig, M. G., & Berry, M. F. (2018). Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis. LUNG CANCER, 115, 75–83.
- Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer
  Yang, C.-F. J., Mayne, N. R., Wang, X., Berry, M. F., Tong, B., Harpole, D. H., … Klapper, J. A. (2018). Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer. ANNALS OF THORACIC SURGERY, 105(3), 924–29.
- The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma
  Cox, M., Yang, C.-F., Speicher, P., Fitch, Z., Gu, L., Davis, R., … Berry, M. (2017). The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma. JOURNAL OF THORACIC ONCOLOGY, 12(1), S1391–S1392.
- Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma
  Yang, C.-F. J., Wang, H., Kumar, A., Wang, X., Hartwig, M. G., D'Amico, T. A., & Berry, M. F. (2017). Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma. CHEST, 152(6), 1239–50.
- Survival after radiation for stage I and II non-small cell lung cancer with positive margins
  Gulack, B. C., Cox, M. L., Yang, C.-F. J., Speicher, P. J., Kara, H. V., D'Amico, T. A., … Hartwig, M. G. (2018). Survival after radiation for stage I and II non-small cell lung cancer with positive margins. JOURNAL OF SURGICAL RESEARCH, 223, 94–101.
- Computed Tomography (CT) Characteristics Associated with the Proposed IASLC/ITMIG TNM Pathologic Staging System for Thymoma
  Padda, S. K., Terrone, D., Khuong, A., Tian, L., Neal, J. W., Riess, J. W., … Wakelee, H. A. (2015). Computed Tomography (CT) Characteristics Associated with the Proposed IASLC/ITMIG TNM Pathologic Staging System for Thymoma. JOURNAL OF THORACIC ONCOLOGY, 10(9), S196.
- Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors
  Padda, S. K., Terrone, D., Tian, L., Khuong, A., Neal, J. W., Riess, J. W., … Wakelee, H. A. (2018). Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors. JOURNAL OF THORACIC IMAGING, 33(3), 176–83.
- Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma
  Gao, R. W., Berry, M. F., Kunder, C. A., Khuong, A. A., Wakelee, H., Neal, J. W., … Shrager, J. B. (2017). Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 154(6), 2092-+.
- Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival
  Berry, M. F., Gao, R., Kunder, C. A., Backhus, L., Khuong, A., Kadoch, M., … Shrager, J. (2018). Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival. CLINICAL LUNG CANCER, 19(1), E47–E51.
- Effect of EGFR Mutations on Survival in Patients following Surgical Resection of Lung Adenocarcinoma
  Laidlaw, G., Gao, R., Ayers, K., Backhus, L., Berry, M., & Shrager, J. (2017). Effect of EGFR Mutations on Survival in Patients following Surgical Resection of Lung Adenocarcinoma. JOURNAL OF THORACIC ONCOLOGY, 12(1), S751.
- Intraoperative costs of video-assisted thoracoscopic lobectomy can be dramatically reduced without compromising outcomes
  Richardson, M. T., Backhus, L. M., Berry, M. F., Vail, D. G., Ayers, K. C., Benson, J. A., … Shrager, J. B. (2018). Intraoperative costs of video-assisted thoracoscopic lobectomy can be dramatically reduced without compromising outcomes. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 155(3), 1267-+.
- FROZEN SECTION OF N2 NODES IS INVALUABLE WHENEVER UNEXPECTED SUSPICIOUS OPERATIVE FINDINGS ARE ENCOUNTERED
  Yang, C.-F. J., D'Amico, T. A., & Berry, M. F. (2016). FROZEN SECTION OF N2 NODES IS INVALUABLE WHENEVER UNEXPECTED SUSPICIOUS OPERATIVE FINDINGS ARE ENCOUNTERED. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 152(6), 1643–44.
- Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials
  Yang, C.-F. J., Hartwig, M. G., D'Amico, T. A., & Berry, M. F. (2016). Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 151(3), 626–28.
- Impact of Radiation on Recurrence Patterns and Survival for Patients Undergoing Lobectomy for Stage IIIA-pN2 Non-Small Cell Lung Cancer
  Yang, C.-F. J., Adil, S. M., Meyerhoff, R. R., Anderson, K. L., Hirji, S. A., Harpole, D., … Berry, M. F. (2015). Impact of Radiation on Recurrence Patterns and Survival for Patients Undergoing Lobectomy for Stage IIIA-pN2 Non-Small Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC.
- The Impact of Post-Operative Therapy on Primary Cardiac Sarcoma
  Wu, Y., Million, L., Moding, E. J., Scott, G., Berry, M., & Ganjoo, K. N. (2018). The Impact of Post-Operative Therapy on Primary Cardiac Sarcoma. The Journal of Thoracic and Cardiovascular Surgery.
- ALL EVIDENCE POINTS TO THE NEED FOR COLLABORATIVE CARE
  Yerokun, B. A., Berry, M. F., & Hartwig, M. G. (2018). ALL EVIDENCE POINTS TO THE NEED FOR COLLABORATIVE CARE. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 156(2), 820–21.
- Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
  Berry, M. F., Canchola, A. J., Gensheimer, M. F., Gomez, S. L., & Cheng, I. (2018). Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis. Clinical Lung Cancer, 19(5), e745–e758.
- Response to: "Comment on: A National Analysis of Longterm Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Nonsmallcell Lung Cancer".
  Yang, C.-F. J., Kumar, A., Berry, M. F., & D'Amico, T. A. (2018). Response to: "Comment on: A National Analysis of Longterm Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Nonsmallcell Lung Cancer". Annals of Surgery.
- Society for Translational Medicine expert consensus on training and certification standards for surgeons and assistants in minimally invasive surgery for lung cancer
  Liu, L., Mei, J., He, J., Gao, S., Li, S., He, J., … Embun, R. (2018). Society for Translational Medicine expert consensus on training and certification standards for surgeons and assistants in minimally invasive surgery for lung cancer. JOURNAL OF THORACIC DISEASE, 10(10), 5666–72.
- Right-sided vs Left-sided Pneumonectomy after Induction Therapy for Non-small-cell Lung Cancer.
  Yang, C.-F. J., Shah, S., Lin, B. K., Vandusen, K., Chan, D. Y., Tan, W., … Berry, M. F. (2018). Right-sided vs Left-sided Pneumonectomy after Induction Therapy for Non-small-cell Lung Cancer. The Annals of Thoracic Surgery.
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Patients with Non-Small Cell Lung Cancer
  Nair, V. S., Li, A. B.-H., Stehr, H., Chabon, J., Chaudhuri, A., Zhou, L., … Diehn, M. (2018). Genomic Profiling of Bronchoalveolar Lavage Fluid in Patients with Non-Small Cell Lung Cancer. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197.
- Examination of Optimal Timing of Post-Surgical Surveillance for Early Stage Lung Cancer Patients and Association with Outcomes
  Colwell, E., Bhandari, P., Benson, J., He, H., Lui, N., Berry, M., … Backhus, L. (2018). Examination of Optimal Timing of Post-Surgical Surveillance for Early Stage Lung Cancer Patients and Association with Outcomes. JOURNAL OF THORACIC ONCOLOGY, 13(10), S819.
- The Impact of Malignant Pleural Mesothelioma Histology on the Use of Surgery and Survival in a Population-Based Analysis
  Yang, C., Mayne, N., Deng, J., Commander, S., D'Amico, T., & Berry, M. (2018). The Impact of Malignant Pleural Mesothelioma Histology on the Use of Surgery and Survival in a Population-Based Analysis. JOURNAL OF THORACIC ONCOLOGY, 13(10), S396–S397.
- The Role of Adjuvant Therapy for Patients with Early Stage Large Cell Neuroendocrine Lung Cancer: A National Analysis
  Raman, V., Yang, C., Jawitz, O., Erkmen, C., Tong, B., D'Amico, T., … Harpole, D. (2018). The Role of Adjuvant Therapy for Patients with Early Stage Large Cell Neuroendocrine Lung Cancer: A National Analysis. JOURNAL OF THORACIC ONCOLOGY, 13(10), S648.
- Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma
  Mao, Y., Yu, Z., You, B., Fang, W., Badgwell, B., Berry, M. F., … Zhou, Q. (2019). Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma. JOURNAL OF THORACIC DISEASE, 11(1), 319–28.
- The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study.
  Yang, C.-F. J., Yendamuri, S., Mayne, N. R., Battoo, A., Wang, H., Meyerhoff, R. R., … D'Amico, T. A. (2018). The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study. The Journal of Thoracic and Cardiovascular Surgery.
- Dosimetric Predictors of Surgical Complications From Esophagectomy After Neoadjuvant Chemoradiation for Esophageal Cancer
  Shah, J. L., Johannet, P., Shaffer, J., Holcombe, C., Koong, A. C., Berry, M., & Chang, D. T. (2015). Dosimetric Predictors of Surgical Complications From Esophagectomy After Neoadjuvant Chemoradiation for Esophageal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), E131.
- A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer.
  Yang, C.-F. J., Kumar, A., Deng, J. Z., Raman, V., Lui, N. S., D'Amico, T. A., & Berry, M. F. (2019). A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer. Annals of Surgery.
- The impact of postoperative therapy on primary cardiac sarcoma.
  Wu, Y., Million, L., Moding, E. J., Scott, G., Berry, M., & Ganjoo, K. N. (2018). The impact of postoperative therapy on primary cardiac sarcoma. The Journal of Thoracic and Cardiovascular Surgery, 156(6), 2194–2203.
- Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma.
  Mao, Y., Yu, Z., You, B., Fang, W., Badgwell, B., Berry, M. F., … Zhou, Q. (2019). Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma. Journal of Thoracic Disease, 11(1), 319–328.
- Society for Translational Medicine expert consensus on training and certification standards for surgeons and assistants in minimally invasive surgery for lung cancer.
  Liu, L., Mei, J., He, J., Gao, S., Li, S., He, J., … Embun, R. (2018). Society for Translational Medicine expert consensus on training and certification standards for surgeons and assistants in minimally invasive surgery for lung cancer. Journal of Thoracic Disease, 10(10), 5666–5672.
- Adjuvant Therapy for Patients with Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
  Raman, V., Jawitz, O. K., Yang, C.-F. J., Tong, B. C., D'Amico, T. A., Berry, M. F., & Harpole, D. H. (2019). Adjuvant Therapy for Patients with Early Large Cell Lung Neuroendocrine Cancer: A National Analysis. The Annals of Thoracic Surgery.
- Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab.
  Yi, J. S., Ready, N., Healy, P., Dumbauld, C., Osborne, R., Berry, M., … Weinhold, K. J. (2017). Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 23(24), 7474–7482.
- Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.
  Anderson, K. L., Mulvihill, M. S., Speicher, P. J., Yerokun, B. A., Gulack, B. C., Nussbaum, D. P., … Hartwig, M. G. (2017). Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors. The Annals of Thoracic Surgery, 104(4), 1221–30.
- Evidence for resection of sarcoma pulmonary metastases: More, but better?
  Berry, M. F. (2017). Evidence for resection of sarcoma pulmonary metastases: More, but better? The Journal of Thoracic and Cardiovascular Surgery, 154(1), 317–18.
- Esophageal Cancer: Improvements in Treatment, Staging, and Now Prognostic Indicators?
  Berry, M. F. (2016). Esophageal Cancer: Improvements in Treatment, Staging, and Now Prognostic Indicators? Seminars in Thoracic and Cardiovascular Surgery, 28(2), 559–60.
- Risk calculators are useful but....
  Wang, X., & Berry, M. F. (2016). Risk calculators are useful but.... The Journal of Thoracic and Cardiovascular Surgery, 151(3), 706–7.
- Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
  Speicher, P. J., Gu, L., Gulack, B. C., Wang, X., D'Amico, T. A., Hartwig, M. G., & Berry, M. F. (2016). Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States. Clinical Lung Cancer, 17(1), 47–55.
- The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer.
  Gulack, B. C., Yang, C.-F. J., Speicher, P. J., Meza, J. M., Gu, L., Wang, X., … Berry, M. F. (2015). The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 90(3), 554–60.
- ACR Appropriateness Criteria Noninvasive Clinical Staging of Primary Lung Cancer.
  de Groot, P. M., Chung, J. H., Ackman, J. B., Berry, M. F., Carter, B. W., Colletti, P. M., … Kanne, J. P. (2019). ACR Appropriateness Criteria Noninvasive Clinical Staging of Primary Lung Cancer. Journal of the American College of Radiology : JACR, 16(5S), S184–S195.
- Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary?
  Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2018). Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary? JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 155(6), 2697–2705.
- A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer
  Yang, C.-F. J., Kumar, A., Klapper, J. A., Hartwig, M. G., Tong, B. C., Harpole, D. H., … D'Amico, T. A. (2019). A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer. ANNALS OF SURGERY, 269(1), 163–71.
- The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study
  Yang, C.-F. J., Yendamuri, S., Mayne, N. R., Battoo, A., Wang, H., Meyerhoff, R. R., … D'Amico, T. A. (2019). The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 158(1), 252–62.
- Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis
  Raman, V., Jawitz, O. K., Yang, C.-F. J., Tong, B. C., D'Amico, T. A., Berry, M. F., & Harpole, D. H. (2019). Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis. ANNALS OF THORACIC SURGERY, 108(2), 377–83.
- Response to Comment on "A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Nonsmall-cell Lung Cancer''
  Yang, C.-F. J., Kumar, A., Berry, M. F., & D'Amico, T. A. (2019). Response to Comment on "A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Nonsmall-cell Lung Cancer''. ANNALS OF SURGERY, 270(2), E47.
- Impact of positive margins and radiation after tracheal adenoid cystic carcinoma resection on survival.
  Jeffrey Yang, C.-F. F., Shah, S., Ramakrishnan, D., Raman, V., Diao, K., Wang, H., … Berry, M. F. (2019). Impact of positive margins and radiation after tracheal adenoid cystic carcinoma resection on survival. The Annals of Thoracic Surgery.
- ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompromised Patients.
  Lee, C., Colletti, P. M., Chung, J. H., Ackman, J. B., Berry, M. F., Carter, B. W., … Kanne, J. P. (2019). ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompromised Patients. Journal of the American College of Radiology : JACR, 16(11S), S331–S339.
- National Evaluation of Short-Term and Intermediate-Term Readmission after Esophagectomy
  Yang, C.-F. J., Wang, Y., He, H., Liou, D., Lui, N., Berry, M. F., … Backhus, L. (2019). National Evaluation of Short-Term and Intermediate-Term Readmission after Esophagectomy. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), S279–S280.
- Management of Benign Esophageal Perforation in the National Inpatient Sample
  Lui, N., Bhandari, P., Backhus, L., Liou, D., Shrager, J., & Berry, M. F. (2019). Management of Benign Esophageal Perforation in the National Inpatient Sample. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), E209.
- Broad Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer
  Nair, V., Hui, A. B.-Y., Chabon, J., Esfahani, M., Stehr, H., Nabet, B., … Diehn, M. (2019). Broad Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 14(10), S747–S748.
- A Multi-Center Analysis of Right vs Left-Sided Pneumonectomy Following Induction Therapy
  Yang, C. J., Mayne, N., Battoo, A., Yendamuri, S., Demmy, T., Mckenna, R., … Berry, M. (2019). A Multi-Center Analysis of Right vs Left-Sided Pneumonectomy Following Induction Therapy. JOURNAL OF THORACIC ONCOLOGY, 14(10), S278.
- A Minimally Invasive Approach to Lobectomy After Induction Therapy Does Not Compromise Survival.
  Jeffrey Yang, C.-F. F., Nwosu, A., Mayne, N. R., Wang, Y.-Y. Y., Raman, V., Meyerhoff, R. R., … Berry, M. F. (2019). A Minimally Invasive Approach to Lobectomy After Induction Therapy Does Not Compromise Survival. The Annals of Thoracic Surgery.
- The Oldest Old: A National Analysis of Outcomes for Patients 90 Years or Older With Lung Cancer.
  Yang, C.-F. J., Brown, A. B., Deng, J. Z., Lui, N. S., Backhus, L. M., Shrager, J. B., … Berry, M. F. (2019). The Oldest Old: A National Analysis of Outcomes for Patients 90 Years or Older With Lung Cancer. The Annals of Thoracic Surgery.
- The influence of hormone replacement therapy on lung cancer incidence and mortality.
  Titan, A. L., He, H., Lui, N., Liou, D., Berry, M., Shrager, J. B., & Backhus, L. M. (2019). The influence of hormone replacement therapy on lung cancer incidence and mortality. The Journal of Thoracic and Cardiovascular Surgery.
- Commentary: Resection of clinical early-stage lung cancer with unexpected nodal disease-can less really be the same?
  Yang, C.-F. J., & Berry, M. F. (2019). Commentary: Resection of clinical early-stage lung cancer with unexpected nodal disease-can less really be the same? The Journal of Thoracic and Cardiovascular Surgery.
- A Patient-Specific Mixed-Reality Visualization Tool for Thoracic Surgical Planning.
  Perkins, S. L., Krajancich, B., Jeffrey Yang, C.-F. F., Hargreaves, B. A., Daniel, B. L., & Berry, M. F. (2020). A Patient-Specific Mixed-Reality Visualization Tool for Thoracic Surgical Planning. The Annals of Thoracic Surgery.
- Transcervical Thymectomy is the Most Cost-Effective Surgical Approach in Myasthenia Gravis.
  Sholtis, C., Teymourtash, M., Berry, M., Backhus, L., Bhandari, P., He, H., … Shrager, J. (2020). Transcervical Thymectomy is the Most Cost-Effective Surgical Approach in Myasthenia Gravis. The Annals of Thoracic Surgery.
- Integrating genomic features for non-invasive early lung cancer detection
  Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., … Diehn, M. (2020). Integrating genomic features for non-invasive early lung cancer detection. NATURE.
- A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma.
  Yang, C.-F. J., Hurd, J., Shah, S. A., Liou, D., Wang, H., Backhus, L. M., … Berry, M. F. (2019). A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma. The Journal of Thoracic and Cardiovascular Surgery.
- Integrating genomic features for non-invasive early lung cancer detection.
  Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., … Diehn, M. (2020). Integrating genomic features for non-invasive early lung cancer detection. Nature, 580(7802), 245–251.
- ACR Appropriateness Criteria® Occupational Lung Diseases.
  Cox, C. W., Chung, J. H., Ackman, J. B., Berry, M. F., Carter, B. W., de Groot, P. M., … Kanne, J. P. (2020). ACR Appropriateness Criteria® Occupational Lung Diseases. Journal of the American College of Radiology : JACR, 17(5S), S188–S197.
- ACR Appropriateness Criteria® Hemoptysis.
  Olsen, K. M., Manouchehr-Pour, S., Donnelly, E. F., Henry, T. S., Berry, M. F., Boiselle, P. M., … Kanne, J. P. (2020). ACR Appropriateness Criteria® Hemoptysis. Journal of the American College of Radiology : JACR, 17(5S), S148–S159.
- Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival.
  Mayne, N. R., Mallipeddi, M. K., Darling, A. J., Jeffrey Yang, C.-F., Eltaraboulsi, W. R., Shoffner, A. R., … Berry, M. F. (2020). Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival. Clinical Lung Cancer.
- Does size matter? A national analysis of the utility of induction therapy for large thymomas.
  Liou, D. Z., Ramakrishnan, D., Lui, N. S., Shrager, J. B., Backhus, L. M., & Berry, M. F. (2020). Does size matter? A national analysis of the utility of induction therapy for large thymomas. Journal of Thoracic Disease, 12(4), 1329–41.
- Reply: The importance of appropriate selection for segmentectomy.
  Jeffrey Yang, C.-F., & Berry, M. F. (2020). Reply: The importance of appropriate selection for segmentectomy. The Journal of Thoracic and Cardiovascular Surgery.
- Sub-solid lung adenocarcinoma in Asian versus Caucasian patients: different biology but similar outcomes
  Lui, N. S., Benson, J., He, H., Imielski, B. R., Kunder, C. A., Liou, D. Z., … Shrager, J. B. (2020). Sub-solid lung adenocarcinoma in Asian versus Caucasian patients: different biology but similar outcomes. JOURNAL OF THORACIC DISEASE, 12(5), 2161–71.
- Sub-solid lung adenocarcinoma in Asian versus Caucasian patients: different biology but similar outcomes.
  Lui, N. S., Benson, J., He, H., Imielski, B. R., Kunder, C. A., Liou, D. Z., … Shrager, J. B. (2020). Sub-solid lung adenocarcinoma in Asian versus Caucasian patients: different biology but similar outcomes. Journal of Thoracic Disease, 12(5), 2161–2171.
- Perioperative Outcomes and 5-year Survival After Open versus Thoracoscopic Sleeve Resection for Lung Cancer.
  Mayne, N. R., Darling, A. J., Raman, V., Balderson, S., Berry, M. F., Harpole, D. H., … Yang, C.-F. J. (2020). Perioperative Outcomes and 5-year Survival After Open versus Thoracoscopic Sleeve Resection for Lung Cancer. Seminars in Thoracic and Cardiovascular Surgery.
- A National Analysis of Treatment Patterns and Outcomes for Patients 80 Years or Older with Esophageal Cancer.
  Yang, C.-F. J., Wang, Y., Raman, V., Patel, D., Lui, N., Backhus, L., … Liou, D. (2020). A National Analysis of Treatment Patterns and Outcomes for Patients 80 Years or Older with Esophageal Cancer. Seminars in Thoracic and Cardiovascular Surgery.
- A National Analysis of Minimally Invasive vs Open Segmentectomy for Stage IA Non-small-cell Lung Cancer.
  Kumar, A., Deng, J., Raman, V., Okusanya, O., Baiu, I., Berry, M. F., … Yang, C.-F. J. (2020). A National Analysis of Minimally Invasive vs Open Segmentectomy for Stage IA Non-small-cell Lung Cancer. Seminars in Thoracic and Cardiovascular Surgery.
- Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis
  Berry, M. F., Canchola, A. J., Gensheimer, M. F., Gomez, S. L., & Cheng, I. (2018). Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis. CLINICAL LUNG CANCER, 19(5), E745–E758.
- Paradoxical Motion on Sniff Test Predicts Greater Improvement Following Diaphragm Plication.
  Patel, D. C., Berry, M. F., Bhandari, P., Backhus, L. M., Raees, S., Trope, W., … Shrager, J. B. (2020). Paradoxical Motion on Sniff Test Predicts Greater Improvement Following Diaphragm Plication. The Annals of Thoracic Surgery.
- KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer.
  Binkley, M. S., Jeon, Y.-J., Nesselbush, M., Moding, E. J., Nabet, B., Almanza, D. S., … Diehn, M. (2020). KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Discovery of a novel shared tumor antigen in human lung cancer.
  Tseng, D., Chiou, S.-H., Yang, X., Reuben, A., Wilhelmy, J., McSween, A., … Davis, M. (2020). Discovery of a novel shared tumor antigen in human lung cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Cancer diagnoses and survival rise as 65-year-olds become Medicare eligible.
  Patel, D. C., He, H., Berry, M. F., Yang, C.-F. J., Trope, W., Lui, N., … Shrager, J. B. (2020). Cancer diagnoses and survival rise as 65-year-olds become Medicare eligible. JOURNAL OF CLINICAL ONCOLOGY, 38(15).
- KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition.
  Binkley, M. S., Jeon, Y.-J. J., Nesselbush, M., Moding, E. J., Nabet, B. Y., Almanza, D., … Diehn, M. (2020). KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition. Cancer Discovery.
- ACR Appropriateness Criteria Blunt Chest Trauma-Suspected Cardiac Injury.
  Stojanovska, J., Hurwitz Koweek, L. M., Chung, J. H., Ghoshhajra, B. B., Walker, C. M., Beache, G. M., … Abbara, S. (2020). ACR Appropriateness Criteria Blunt Chest Trauma-Suspected Cardiac Injury. Journal of the American College of Radiology : JACR, 17(11S), S380–S390.
- Early Discharge Does Not Equate to Early Return for Patients Undergoing Lobectomy for Lung Cancer: A National Analysis
  Patel, D. C., Leipzig, M., Yang, C.-F. J., Wang, Y., Shrager, J. B., Backhus, L. M., … Berry, M. F. (2020). Early Discharge Does Not Equate to Early Return for Patients Undergoing Lobectomy for Lung Cancer: A National Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC.
- Greater Ipsilateral Rectus Muscle Atrophy after Robotic Thoracic Surgery Compared to Open and VATS Approaches
  Wang, Y., Bhandari, P., Trope, W., Guenthart, B. A., Guo, H. H., Liou, D., … Lui, N. (2020). Greater Ipsilateral Rectus Muscle Atrophy after Robotic Thoracic Surgery Compared to Open and VATS Approaches. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC.
- Endoscopic instead of surgical resection of tracheal ACC - maybe, but not so fast.
  Shah, S., Jeffrey Yang, C.-F., & Berry, M. F. (2020). Endoscopic instead of surgical resection of tracheal ACC - maybe, but not so fast. The Annals of Thoracic Surgery.
- Resection of a Giant Epithelioid Hemangioendothelioma Arising from the Superior Vena Cava.
  Elliott, I. A., Kasinpila, P., Guenthart, B. A., MacArthur, J. W., & Berry, M. F. (2021). Resection of a Giant Epithelioid Hemangioendothelioma Arising from the Superior Vena Cava. The Annals of Thoracic Surgery.
- Strong for Surgery: Association Between Bundled Risk Factors and Outcomes After Major Elective Surgery in the VA Population.
  Liou, D. Z., Patel, D. C., Bhandari, P., Wren, S. M., Marshall, N. J., Harris, A. H., … Backhus, L. M. (2021). Strong for Surgery: Association Between Bundled Risk Factors and Outcomes After Major Elective Surgery in the VA Population. World Journal of Surgery.
- A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer
  Yang, C.-F. J., Kumar, A., Deng, J. Z., Raman, V., Lui, N. S., D'Amico, T. A., & Berry, M. F. (2021). A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer. ANNALS OF SURGERY, 273(3), 595–605.
- Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
  Chiou, S.-H. H., Tseng, D., Reuben, A., Mallajosyula, V., Molina, I. S., Conley, S., … Davis, M. M. (2021). Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity, 54(3), 586–602.e8.
- Use of a Personalized Multimedia Education Platform Improves Preoperative Teaching for Lung Cancer Patients.
  Benson, J., Bhandari, P., Lui, N., Berry, M., Liou, D. Z., Shrager, J., … Backhus, L. M. (2021). Use of a Personalized Multimedia Education Platform Improves Preoperative Teaching for Lung Cancer Patients. Seminars in Thoracic and Cardiovascular Surgery.
- Cancer diagnoses and survival rise as 65-year-olds become Medicare-eligible.
  Patel, D. C., He, H., Berry, M. F., Yang, C.-F. J., Trope, W. L., Wang, Y., … Shrager, J. B. (2021). Cancer diagnoses and survival rise as 65-year-olds become Medicare-eligible. Cancer.
- Endoscopic Instead of Surgical Resection of Tracheal ACC: Maybe, But Not So Fast... reply
  Shah, S. A., Yang, C.-F. J., & Berry, M. F. (2021). Endoscopic Instead of Surgical Resection of Tracheal ACC: Maybe, But Not So Fast... reply. ANNALS OF THORACIC SURGERY, 111(3), 1094.
- ACR Appropriateness Criteria Intensive Care Unit Patients.
  Laroia, A. T., Donnelly, E. F., Henry, T. S., Berry, M. F., Boiselle, P. M., Colletti, P. M., … Kanne, J. P. (2021). ACR Appropriateness Criteria Intensive Care Unit Patients. Journal of the American College of Radiology : JACR, 18(5S), S62–S72.
- Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer.
  Binkley, M. S., Jeon, Y.-J., Nesselbush, M., Moding, E. J., Nabet, B., Almanza, D., … Diehn, M. (2021). Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer
  Yang, C.-F. J., Shah, S. A., Lin, B. K., VanDusen, K. W., Chan, D. Y., Tan, W. D., … Berry, M. F. (2019). Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer. ANNALS OF THORACIC SURGERY, 107(4), 1074–1081.
- Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer
  Yang, C.-F. J., Chan, D. Y., Shah, S. A., Yemkun, B. A., Wang, X. F., D'Amico, T. A., … Harpole Jr, D. H. (2018). Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer. ANNALS OF SURGERY, 268(6), 1105–1112.
- Surgery versus optimal medical management of early-stage small cell lung cancer.
  Yang, C.-F. J., Chan, D. Y., Yerokun, B., Wang, X. F., Tong, B. C., D'Amico, T. A., … Harpole, D. (2016). Surgery versus optimal medical management of early-stage small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY, 34(15).
- IMPACTS OF CEREBROVASCULAR AND NEURODEGENERATIVE DISEASES ON SURVIVAL OF LUNG CANCER PATIENTS
  Kravchenko, J., Berry, M. F., Arbeev, K. G., Lyerly, H., Yashin, A. I., & Akushevich, I. (2015). IMPACTS OF CEREBROVASCULAR AND NEURODEGENERATIVE DISEASES ON SURVIVAL OF LUNG CANCER PATIENTS. GERONTOLOGIST, 55, 496.
- Early Discharge after Lobectomy for Lung Cancer does not Equate to Early Readmission.
  Patel, D. C., Leipzig, M., Jeffrey Yang, C.-F., Wang, Y., Shrager, J. B., Backhus, L. M., … Berry, M. F. (2021). Early Discharge after Lobectomy for Lung Cancer does not Equate to Early Readmission. The Annals of Thoracic Surgery.
- Influence of facility volume on long-term survival of patients undergoing esophagectomy for esophageal cancer.
  Patel, D. C., Jeffrey Yang, C.-F., He, H., Liou, D. Z., Backhus, L. M., Lui, N. S., … Berry, M. F. (2021). Influence of facility volume on long-term survival of patients undergoing esophagectomy for esophageal cancer. The Journal of Thoracic and Cardiovascular Surgery.
- Short-term and intermediate-term readmission after esophagectomy
  Wang, Y., Yang, C.-F. J., He, H., Buchan, J. M., Patel, D. C., Liou, D. Z., … Backhus, L. M. (2021). Short-term and intermediate-term readmission after esophagectomy. JOURNAL OF THORACIC DISEASE.
- Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample
  Patel, D. C., Bhandari, P., Epstein, D. J., Liou, D. Z., Backhus, L. M., Berry, M. F., … Lui, N. S. (2021). Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample. JOURNAL OF THORACIC DISEASE.
- Induction therapy is not associated with improved survival in large cT4N0 non-small cell lung cancers.
  Sun, B. J., Bhandari, P., Jeffrey Yang, C.-F., Berry, M. F., Shrager, J. B., Backhus, L. M., … Liou, D. Z. (2021). Induction therapy is not associated with improved survival in large cT4N0 non-small cell lung cancers. The Annals of Thoracic Surgery.
- Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample.
  Patel, D. C., Bhandari, P., Epstein, D. J., Liou, D. Z., Backhus, L. M., Berry, M. F., … Lui, N. S. (2021). Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample. Journal of Thoracic Disease, 13(8), 4977–4987.
- Short-term and intermediate-term readmission after esophagectomy.
  Wang, Y., Yang, C.-F. J., He, H., Buchan, J. M., Patel, D. C., Liou, D. Z., … Backhus, L. M. (2021). Short-term and intermediate-term readmission after esophagectomy. Journal of Thoracic Disease, 13(8), 4678–4689.
- Treatment for Early-Stage Lung Cancer Should Never Be "Just a Wedge".
  Berry, M. F. (2021). Treatment for Early-Stage Lung Cancer Should Never Be "Just a Wedge". The Annals of Thoracic Surgery.
- Rationale and design of a mechanistic clinical trial of JAK inhibition to prevent ventilator-induced diaphragm dysfunction.
  Shrager, J. B., Wang, Y., Lee, M., Nesbit, S., Trope, W., Konsker, H., … Tang, H. (2021). Rationale and design of a mechanistic clinical trial of JAK inhibition to prevent ventilator-induced diaphragm dysfunction. Respiratory Medicine, 189, 106620.
- Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation.
  Erwin, P. A., Lee, A. C., Ahmad, U., Antonoff, M., Arndt, A., Backhus, L., … Ferguson, M. K. (2021). Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation. The Annals of Thoracic Surgery.
- Perioperative Outcomes After Combined Esophagectomy and Lung Resection.
  Patel, D. C., Bhandari, P., Shrager, J. B., Berry, M. F., Backhus, L. M., Lui, N. S., & Liou, D. Z. (2021). Perioperative Outcomes After Combined Esophagectomy and Lung Resection. The Journal of Surgical Research, 270, 413–420.
- A new model using artificial intelligence to predict recurrence after surgical resection of stage I-II non-small cell lung cancer.
  Lui, N., Wei, N., Trope, W., Nesbit, S., Bhandari, P., Lee, C.-H., … Yang, E. (2021). A new model using artificial intelligence to predict recurrence after surgical resection of stage I-II non-small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Silver Nitrate-Coated Versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial.
  Shrager, J. B., Bhatnagar, R., Kearney, C. T., Retzlaff, N. P., Cohen, E., Stanton, A. E., … Maskell, N. A. (2022). Silver Nitrate-Coated Versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial. Annals of the American Thoracic Society.
- Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma.
  Byrd, C. T., Trope, W. L., Bhandari, P., Konsker, H. B., Moradi, F., Lui, N. S., … Shrager, J. B. (2022). Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma. The Journal of Thoracic and Cardiovascular Surgery.
- Half of Anastomotic Leaks after Esophagectomy are Undetected on Initial Postoperative Esophagram.
  Elliott, I. A., Berry, M. F., Trope, W., Lui, N. S., Guenthart, B. A., Liou, D. Z., … Shrager, J. B. (2022). Half of Anastomotic Leaks after Esophagectomy are Undetected on Initial Postoperative Esophagram. The Annals of Thoracic Surgery.
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.
  Nair, V. S., Hui, A. B., Chabon, J. J., Shahrokh Esfahani, M., Stehr, H., Nabet, B. Y., … Diehn, M. (2022). Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer. Cancer Research.
- Lobar versus sublobar resection in clinical stage IA primary lung cancer with occult N2 disease.
  Liou, D. Z., Chan, M., Bhandari, P., Lui, N. S., Backhus, L. M., Shrager, J. B., & Berry, M. F. (2022). Lobar versus sublobar resection in clinical stage IA primary lung cancer with occult N2 disease. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery.
- Eligibility for Lung Cancer Screening Among Women Receiving Screening for Breast Cancer.
  Titan, A. L., Baiu, I., Liou, D., Lui, N. S., Berry, M., Shrager, J., & Backhus, L. (2022). Eligibility for Lung Cancer Screening Among Women Receiving Screening for Breast Cancer. JAMA Network Open, 5(9), e2233840.
- Risk of adenocarcinoma in patients with a suspicious ground-glass opacity: a retrospective review
  Roy, E., Shrager, J., Benson, J., Trope, W. L., Bhandari, P., Lui, N., … Berry, M. F. (2022). Risk of adenocarcinoma in patients with a suspicious ground-glass opacity: a retrospective review. JOURNAL OF THORACIC DISEASE.
- Treatment for Early-Stage Lung Cancer Should Never Be "Just a Wedge" COMMENT
  Berry, M. F. (2022). Treatment for Early-Stage Lung Cancer Should Never Be "Just a Wedge" COMMENT. ANNALS OF THORACIC SURGERY, 114(3), 997–998.
- Treatment and Outcomes of Proximal Esophageal Squamous Cell Carcinoma.
  Patel, D. C., Yang, C.-F. J., Liou, D. Z., & Berry, M. F. (2022). Treatment and Outcomes of Proximal Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology.
- Risk of adenocarcinoma in patients with a suspicious ground-glass opacity: a retrospective review.
  Roy, E., Shrager, J., Benson, J., Trope, W. L., Bhandari, P., Lui, N., … Berry, M. F. (2022). Risk of adenocarcinoma in patients with a suspicious ground-glass opacity: a retrospective review. Journal of Thoracic Disease, 14(11), 4236–4245.
- Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma.
  Wong, L.-Y., Liou, D. Z., Vitzthum, L. K., Backhus, L. M., Lui, N. S., Chang, D., … Berry, M. F. (2022). Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology.
- An Investigation of Cancer-Directed Surgery for Different Histologic Subtypes of Malignant Pleural Mesothelioma.
  Mansur, A., Potter, A., Zurovec, A. J., Nathamuni, K. V., Meyerhoff, R. R., Berry, M. F., … Jeffrey Yang, C.-F. (2022). An Investigation of Cancer-Directed Surgery for Different Histologic Subtypes of Malignant Pleural Mesothelioma. Chest.
- ASO Author Reflections: Timing of Surgery and Chemoradiation for Esophageal Squamous Cell Carcinoma.
  Wong, L.-Y., & Berry, M. F. (2023). ASO Author Reflections: Timing of Surgery and Chemoradiation for Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology.
- The Impact of Age and Need for Emergent Surgery in Paraesophageal Hernia Repair Outcomes.
  Wong, L.-Y. Y., Parsons, N., David, E. A., Burfeind, W., & Berry, M. F. (2023). The Impact of Age and Need for Emergent Surgery in Paraesophageal Hernia Repair Outcomes. The Annals of Thoracic Surgery.
- ASO Visual Abstract: Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma.
  Wong, L.-Y. Y., Liou, D. Z., Vitzthum, L. K., Backhus, L. M., Lui, N. S., Chang, D., … Berry, M. F. (2023). ASO Visual Abstract: Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology.
- Consequences of a Failed Nonoperative Approach in Paraesophageal Hernia Management.
  Wong, L.-Y. Y., & Berry, M. F. (2023). Consequences of a Failed Nonoperative Approach in Paraesophageal Hernia Management. The Annals of Thoracic Surgery.
- Surgical Management of Esophageal Perforation: Examining Trends in a Multi-Institutional Cohort.
  Wong, L.-Y. Y., Leipzig, M., Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2023). Surgical Management of Esophageal Perforation: Examining Trends in a Multi-Institutional Cohort. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Characterization of Epidural Analgesia Interruption and Associated Outcomes After Esophagectomy.
  Byrd, C. T., Kim, R. K., Manapat, P., He, H., Tsui, B. C., Shrager, J. B., … Liou, D. Z. (2023). Characterization of Epidural Analgesia Interruption and Associated Outcomes After Esophagectomy. The Journal of Surgical Research, 290, 92–100.
- ASO Visual Abstract: Treatment and Outcomes ofProximal Esophageal Squamous Cell Carcinoma.
  Patel, D. C., Yang, C.-F. J., Liou, D. Z., & Berry, M. F. (2023). ASO Visual Abstract: Treatment and Outcomes ofProximal Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology.
- Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.
  Iyengar, P., All, S., Berry, M. F., Boike, T. P., Bradfield, L., Dingemans, A.-M. C., … Guckenberger, M. (2023). Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline. Practical Radiation Oncology.
- The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancer.
  Wong, L.-Y., Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2023). The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancer. JTCVS Open, 14, 547–560.
- The Role of Salvage Surgery After Definitive Radiation for Non-small-cell Lung Cancer.
  Rosenstein, A. L., Potter, A. L., Senthil, P., Raman, V., Kumar, A., Muniappan, A., … Jeffrey Yang, C.-F. (2023). The Role of Salvage Surgery After Definitive Radiation for Non-small-cell Lung Cancer. The Annals of Thoracic Surgery.
- Does delaying surgery following induction chemotherapy compromise survival in patients with mesothelioma?
  Wong, L.-Y., Baiu, I., Leipzig, M., Titan, A., Liou, D. Z., Lui, N., … Backhus, L. (2023). Does delaying surgery following induction chemotherapy compromise survival in patients with mesothelioma? JOURNAL OF CANCER METASTASIS AND TREATMENT, 9.
- Consequences of a Failed Nonoperative Approach in Paraesophageal Hernia Management
  Wong, L.-Y., & Berry, M. F. (2023). Consequences of a Failed Nonoperative Approach in Paraesophageal Hernia Management. ANNALS OF THORACIC SURGERY, 116(4), 860.
- Consequences of a Failed Nonoperative Approach in Paraesophageal Hernia Management
  Wong, L.-Y., & Berry, M. F. (2023). Consequences of a Failed Nonoperative Approach in Paraesophageal Hernia Management. ANNALS OF THORACIC SURGERY, 116(4), 860.
- Impact of hyperthermic intrathoracic chemotherapy (HITHOC) during resection of pleural mesothelioma on patient survival
  Elliott, I. A., He, H., Lui, N. S., Liou, D. Z., Guenthart, B. A., Shrager, J. B., … Backhus, L. M. (2023). Impact of hyperthermic intrathoracic chemotherapy (HITHOC) during resection of pleural mesothelioma on patient survival. JOURNAL OF THORACIC DISEASE.
- ACR Appropriateness Criteria® Incidentally Detected Indeterminate Pulmonary Nodule.
  Martin, M. D., Henry, T. S., Berry, M. F., Johnson, G. B., Kelly, A. M., Ko, J. P., … Donnelly, E. F. (2023). ACR Appropriateness Criteria® Incidentally Detected Indeterminate Pulmonary Nodule. Journal of the American College of Radiology : JACR, 20(11S), S455–S470.
- Outcomes of a Failed Observation Approach for Paraesophageal Hernia
  Wong, L.-yeng, Leipzig, M., Elliott, I. A., Lui, N., Liou, D., Backhus, L. M., … Berry, M. (2023). Outcomes of a Failed Observation Approach for Paraesophageal Hernia. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- Outcomes of a Failed Observation Approach for Paraesophageal Hernia
  Wong, L.-yeng, Leipzig, M., Elliott, I. A., Lui, N., Liou, D., Backhus, L. M., … Berry, M. (2023). Outcomes of a Failed Observation Approach for Paraesophageal Hernia. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- Impact of hyperthermic intrathoracic chemotherapy (HITHOC) during resection of pleural mesothelioma on patient survival.
  Elliott, I. A., He, H., Lui, N. S., Liou, D. Z., Guenthart, B. A., Shrager, J. B., … Backhus, L. M. (2023). Impact of hyperthermic intrathoracic chemotherapy (HITHOC) during resection of pleural mesothelioma on patient survival. Journal of Thoracic Disease, 15(11), 6140–6150.
- Risk of developing subsequent primary lung cancer after receiving radiation for breast cancer.
  Wong, L.-Y., Kapula, N., He, H., Guenthart, B. A., Vitzthum, L. K., Horst, K., … Elliott, I. A. (2023). Risk of developing subsequent primary lung cancer after receiving radiation for breast cancer. JTCVS Open, 16, 919–928.
- The impact of refusing esophagectomy for treatment of locally advanced esophageal adenocarcinoma.
  Wong, L.-Y., Elliott, I. A., Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2023). The impact of refusing esophagectomy for treatment of locally advanced esophageal adenocarcinoma. JTCVS Open, 16, 987–995.
- Comparison of failure to rescue in younger versus elderly patients following lung cancer resection.
  Wang, Y., Kapula, N., Yang, C.-F. J., Manapat, P., Elliott, I. A., Guenthart, B. A., … Liou, D. Z. (2023). Comparison of failure to rescue in younger versus elderly patients following lung cancer resection. JTCVS Open, 16, 855–872.
- Commentary: Re-consult surgery for lung cancer patients? The role of resection after initial non-operative therapy.
  Lin, N., & Berry, M. F. (2024). Commentary: Re-consult surgery for lung cancer patients? The role of resection after initial non-operative therapy. The Journal of Thoracic and Cardiovascular Surgery.
- Impact of guideline therapy on survival of patients with stage I-III epithelioid mesothelioma.
  Liou, D. Z., Wang, Y., Bhandari, P., Shrager, J. B., Lui, N. S., Backhus, L. M., & Berry, M. F. (2023). Impact of guideline therapy on survival of patients with stage I-III epithelioid mesothelioma. Journal of Thoracic Disease, 15(12), 6661–6673.
- Clinical Impact of EGFR vs KRAS Mutations in Multifocal Lung Adenocarcinoma
  Jiang, J., Berry, M. F., Lui, N. S., Liou, D. Z., Trope, W. L., Backhus, L. M., & Shrager, J. B. (2023). Clinical Impact of EGFR vs KRAS Mutations in Multifocal Lung Adenocarcinoma. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC.
- Surgical revision of the postesophagectomy gastric conduit to address poor emptying.
  Wong, L.-Y., Rivera, M. F., Liou, D. Z., & Berry, M. F. (2024). Surgical revision of the postesophagectomy gastric conduit to address poor emptying. JTCVS Techniques, 23, 132–140.
- Outcomes of surgery for catastrophic hiatal hernia presentations.
  Wong, L.-Y., Leipzig, M., Elliott, I. A., Liou, D. Z., Backhus, L. M., Shrager, J. B., & Berry, M. F. (2024). Outcomes of surgery for catastrophic hiatal hernia presentations. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 28(3), 285–286.
- Lepidic-Type Lung Adenocarcinomas: Is It Safe to Observe for Growth Prior to Treating?
  Wong, L.-Y. Y., Elliott, I. A., Liou, D. Z., Backhus, L. M., Lui, N. S., Shrager, J. B., & Berry, M. F. (2024). Lepidic-Type Lung Adenocarcinomas: Is It Safe to Observe for Growth Prior to Treating? The Annals of Thoracic Surgery.
- The Impact of Immunotherapy Use in Stage IIIA (T1-2N2) NSCLC: A Nationwide Analysis.
  Wong, L.-Y. Y., Liou, D. Z., Roy, M., Elliott, I. A., Backhus, L. M., Lui, N. S., … Berry, M. F. (2024). The Impact of Immunotherapy Use in Stage IIIA (T1-2N2) NSCLC: A Nationwide Analysis. JTO Clinical and Research Reports, 5(3), 100654.
- Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery.
  Randle, R. J., Bhandari, P., He, H., Berry, M. F., Backhus, L. M., Lui, N. S., … Shrager, J. B. (2024). Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery. Annals of Surgical Oncology.
- genRCT: a statistical analysis framework for generalizing RCT findings to real-world population.
  Lee, D., Yang, S., Berry, M., Stinchcombe, T., Cohen, H. J., & Wang, X. (2024). genRCT: a statistical analysis framework for generalizing RCT findings to real-world population. Journal of Biopharmaceutical Statistics, 1–20.
- Randomized controlled trials in lung cancer surgery: How are we doing?
  Wong, L.-Y. Y., Li, Y., Elliott, I. A., Backhus, L. M., Berry, M. F., Shrager, J. B., & Oh, D. S. (2024). Randomized controlled trials in lung cancer surgery: How are we doing? JTCVS Open, 18, 234–252.
- The Society of Thoracic Surgeons Expert Consensus Document on the Surgical Management of Thymomas.
  Liou, D. Z., Berry, M. F., Brown, L. M., Demmy, T. L., Huang, J., Khullar, O. V., … Hayanga, J. W. (2024). The Society of Thoracic Surgeons Expert Consensus Document on the Surgical Management of Thymomas. The Annals of Thoracic Surgery.
- What is an Adequate Margin During Sublobar Resection of =3cm N0 Subsolid Lung Adenocarcinomas?
  Kamtam, D. N., Berry, M. F., Lui, N. S., Satoyoshi, M., Elliott, I. A., Liou, D. Z., … Shrager, J. B. (2024). What is an Adequate Margin During Sublobar Resection of =3cm N0 Subsolid Lung Adenocarcinomas? The Annals of Thoracic Surgery.
- Barriers to Completing Low Dose Computed Tomography Scan for Lung Cancer Screening.
  Wong, L.-Y. Y., Choudhary, S., Kapula, N., Lin, M., Elliott, I. A., Guenthart, B. A., … Lui, N. S. (2024). Barriers to Completing Low Dose Computed Tomography Scan for Lung Cancer Screening. Clinical Lung Cancer.
- ASO Visual Abstract: Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery.
  Randle, R. J., Bhandari, P., He, H., Berry, M. F., Backhus, L. M., Lui, N. S., … Shrager, J. B. (2024). ASO Visual Abstract: Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery. Annals of Surgical Oncology.
- SURGICAL REVISION OF THE POSTESOPHAGECTOMY GASTRIC CONDUIT TO ADDRESS POOR EMPTYING REPLY
  Wong, L.-Y., & Berry, M. F. (2024). SURGICAL REVISION OF THE POSTESOPHAGECTOMY GASTRIC CONDUIT TO ADDRESS POOR EMPTYING REPLY. JTCVS TECHNIQUES, 24, 218.
- Reply: Surgical revision of the postesophagectomy gastric conduit to address poor emptying.
  Wong, L.-Y. Y., & Berry, M. F. (2024). Reply: Surgical revision of the postesophagectomy gastric conduit to address poor emptying. JTCVS Techniques, 24, 218.
- Impacts of Positive Margins and Surgical Extent on Outcomes after Early-Stage Lung Cancer Resection.
  Wong, L.-Y. Y., Dale, R., Kapula, N., Elliott, I. A., Liou, D. Z., Backhus, L. M., … Berry, M. F. (2024). Impacts of Positive Margins and Surgical Extent on Outcomes after Early-Stage Lung Cancer Resection. The Annals of Thoracic Surgery.
- Clinical impact of EGFR and KRAS mutations in surgically treated unifocal and multifocal lung adenocarcinoma.
  Jiang, J., Berry, M. F., Lui, N. S., Liou, D. Z., Trope, W. L., Backhus, L. M., & Shrager, J. B. (2024). Clinical impact of EGFR and KRAS mutations in surgically treated unifocal and multifocal lung adenocarcinoma. Translational Lung Cancer Research, 13(6), 1222–1231.
- Discussion to: Lung resection after initial nonoperative treatment for non - small cell lung cancer
  Dunne, E., Berry, M. F., & Jones, D. R. (2024). Discussion to: Lung resection after initial nonoperative treatment for non - small cell lung cancer. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 168(2), 374–375.
- Population-Based Analysis of Local Therapies for Large (>7 cm) Non-Small Cell Lung Cancer Tumors
  Patel, D. C., He, H., Liou, D. Z., Speicher, P. J., & Berry, M. F. (2024). Population-Based Analysis of Local Therapies for Large (>7 cm) Non-Small Cell Lung Cancer Tumors. THORACIC RESEARCH AND PRACTICE, 25(4).
- JAK inhibition with tofacitinib rapidly increases contractile force in human skeletal muscle.
  Shrager, J. B., Randle, R., Lee, M., Ahmed, S. S., Trope, W., Lui, N., … Tang, H. (2024). JAK inhibition with tofacitinib rapidly increases contractile force in human skeletal muscle. Life Science Alliance, 7(11).
- Greater ipsilateral rectus muscle atrophy after robotic thoracic surgery compared with open and video-assisted thoracoscopic surgery approaches.
  Wang, Y., Randle, R. J., Bhandari, P., He, H., Trope, W. L., Guenthart, B. A., … Lui, N. S. (2024). Greater ipsilateral rectus muscle atrophy after robotic thoracic surgery compared with open and video-assisted thoracoscopic surgery approaches. JTCVS Open, 20, 202–209.
- The Role of Primary Care Providers in Lung Cancer Screening: A Cross-Sectional Survey.
  Wong, L.-Y. Y., Kapula, N., Kang, A., Phadke, A. J., Schechtman, A. D., Elliott, I. A., … Lui, N. S. (2024). The Role of Primary Care Providers in Lung Cancer Screening: A Cross-Sectional Survey. Clinical Lung Cancer.
- Segmentectomy vs Lobectomy for Non-Small Cell Lung Cancer: The Impact of Tumor Location.
  Wong, L.-Y. Y., Kapula, N., Elliott, I. A., Liou, D. Z., Backhus, L. M., Lui, N. S., … Berry, M. F. (2024). Segmentectomy vs Lobectomy for Non-Small Cell Lung Cancer: The Impact of Tumor Location. Annals of Thoracic Surgery Short Reports, 2(3), 458–463.
- The Impact of Tumor Size on Node Involvement in Typical Lung Carcinoids.
  Elliott, I. A., Liou, D. Z., Lui, N. S., Backhus, L. M., Shrager, J. B., Myall, N., & Berry, M. F. (2023). The Impact of Tumor Size on Node Involvement in Typical Lung Carcinoids. Annals of Thoracic Surgery Short Reports, 1(4), 543–547.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Closed Trials

Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter

Specializing In

Practice Locations

Thoracic Surgery Clinic in Palo Alto Palo Alto, CA

Palo Alto, CA

Thoracic Surgery Clinic in Palo Alto

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Thoracic Cancer Program in Palo Alto Palo Alto, CA

Palo Alto, CA

Thoracic Cancer Program in Palo Alto

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Esophagus Center Redwood City, CA

Redwood City, CA

Esophagus Center

420 Broadway Street, Pavilion D 2nd Floor

Redwood City , CA 94063

(650) 736-5555

More Clinic Information

Chest Wall Surgery Program Palo Alto, CA

Palo Alto, CA

Chest Wall Surgery Program

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(46 Ratings)

Overall Rating

4.9/5

View Ratings by Category

5.0/5

Friendliness

4.9/5

Explanations

4.9/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(330 reviews)

Dr Berry has always been carrying of my situation as he was the 3rd doctor I visited after being infected with MRSA which I got from a surgery from 1st doctor. Dr Berry successfully removed damaged tissue and 2 sections of ribs!

Nov 2024

•

Verified SHC Patient

Very nice

Nov 2024

•

Verified SHC Patient

Extremely knowledgeable, explained all the options, and kind.

Oct 2024

•

Verified SHC Patient

Dr Berry is kind caring thorough and has excellent follow through

Oct 2024

•

Verified SHC Patient

Always enjoy talking to him he is very kind and personable. Often remarks about additional things besides just medical stuff, but professionally keeps it short.

Oct 2024

•

Verified SHC Patient

My first consultation in person visit and this video follow-up visit with Dr. Mark Berry both went well. I will gladly recommend Dr. Berry to a friend or family. Dr. Berry is very pleasant and approachable. He is very knowledgeable. I fully trust him to take care of my medical issue.

Oct 2024

•

Verified SHC Patient

GREAT!!!

Oct 2024

•

Verified SHC Patient

He is very personable and easy to talk to. I am lucky to have him as my doctor

Oct 2024

•

Verified SHC Patient

Dr Berry covered all aspects of the surgery procedure.

Sep 2024

•

Verified SHC Patient

Seems to be a very knowledgeable person and he knows what he is doing. Knew my medical background and talked about a solution with me , which I think is going in the right track towards my getting better.

Sep 2024

•

Verified SHC Patient

Dr. Berry is the best. He has followed me for more than 10 years. I trust him and the treatment he has given me.

Sep 2024

•

Verified SHC Patient

Dr Berry was very professional. Understood my health issues and was confident a procedure was possible to address my health issue.

Sep 2024

•

Verified SHC Patient

I appreciate Dr Berrys expertise and care for me.

Sep 2024

•

Verified SHC Patient

Thank you Dr. Berry for taking care of me. I truly appreciate you and your staff.

Aug 2024

•

Verified SHC Patient

Dr. Berry has a great bedside manner, easy to communicate with, and shows caring attitude!

Aug 2024

•

Verified SHC Patient

Did a good job of explaining potential treatment.

Aug 2024

•

Verified SHC Patient

Amazing person and doctor â ¤ï¸

Jul 2024

•

Verified SHC Patient

Great doctor and really nice.

Jul 2024

•

Verified SHC Patient

Dr. Berry was very personable and knowledgeable. My experience with the entire care team (other doctors and teams) has been outstanding and Dr. Berry follows in the same pattern. I am more than pleased being under his care.

Jul 2024

•

Verified SHC Patient

An expert with a sense of humor. He explained items with great ease and expanded on portions of my treatment that others had not bothered. Well done Dr. Berry!

Jul 2024

•

Verified SHC Patient

He was patient and answered all our questions.

Jun 2024

•

Verified SHC Patient

Dr Berry was very patient and took time to answer all my questions.

Jun 2024

•

Verified SHC Patient

Excellent call. Thanks! Heâ€™s the best!!!

Jun 2024

•

Verified SHC Patient

He is excellent

Jun 2024

•

Verified SHC Patient

Dr. Berry is detailed oriented and reviewed my old medical records. He explained my condition, work up and treatment options well. I appreciate his expertise and kindness.

Jun 2024

•

Verified SHC Patient

Meeting with Dr. Berry was excellent. He provided a concise summary of my test results, and answered all questions. He also asked a few questions concerning my overall health. As well as future plans, with explanations/discussions on options and rationale for each. That's as good as it gets! thanks!

May 2024

•

Verified SHC Patient

So wonderful!!

May 2024

•

Verified SHC Patient

Dr Berry is great kind caring thorough and very competent

May 2024

•

Verified SHC Patient

Dr. Barry is excellent.

May 2024

•

Verified SHC Patient

I thank God for leading me to Dr Berry.

May 2024

•

Verified SHC Patient

He is an excellent doctor!

Apr 2024

•

Verified SHC Patient

Excellent physician with a great reputation.

Apr 2024

•

Verified SHC Patient

He has done surgery on me before. He is very informative and gets straight to the point. Very happy with his care.

Apr 2024

•

Verified SHC Patient

Appreciate Dr. Berry's expertise, skills, professionalism, preparedness, compassion. Extremely grateful for all of Dr. Berry's efforts with my care.

Apr 2024

•

Verified SHC Patient

Dr Berry is thoughtful and clear when providing explanations and answering questions. He is thorough when following up after surgery. Everyone in his service has been kind and considerate when communicating with me. They have replied quickly and made sure I have everything I need. I have consistently felt cared for, believed and in safe hands. Following a lot of medical treatment in the last 3 years, Dr Berry and his staff stand out as exemplary.

Apr 2024

•

Verified SHC Patient

He was detailed and understandable. He answered all of my questions. He reassured me of future actions.

Apr 2024

•

Verified SHC Patient

Excellent communicator. Answered our questions without feeling rushed.

Mar 2024

•

Verified SHC Patient

Dr. Berry took the time to explain the different surgical procedures that could be considered. We especially appreciated when he drew an illustration when explaining, to make it easier for us to understand. This was done over video conference and it felt like we were there in person. Dr. Berry is a kind, caring and extremely knowledgeable professional. We are grateful to be able to have this visit with him.

Mar 2024

•

Verified SHC Patient

Dr. Berry was very professional and answered all of my questions. He was very polite.......

Mar 2024

•

Verified SHC Patient

Dr. Berry's communication is direct, positive, and encouraging. He listens well!

Mar 2024

•

Verified SHC Patient

Dr. Mark Berry is very thorough and answered all our questions. He is very knowledgeable in his field of expertise and very personable when conducting the video appointment.

Mar 2024

•

Verified SHC Patient

Extremely grateful to have an appointment with him.

Mar 2024

•

Verified SHC Patient

He is compassionate, knowledgeable, and sensitive to my needs and feelings. I feel totally safe in his care.

Mar 2024

•

Verified SHC Patient

Dr. Berry was extremely knowledgeable and comforting. Thank you!

Feb 2024

•

Verified SHC Patient

Dr Mark Berry is an excellent doctor. He saved my life. Stanford is lucky to have him.

Feb 2024

•

Verified SHC Patient

Dr. Barry is excellent and might he does appreciate everything that he has done for me and I donâ€™t know if I would be able to trust another doctor if I had to

Feb 2024

•

Verified SHC Patient

Excellent Dr !!

Feb 2024

•

Verified SHC Patient

No, He is great.

Feb 2024

•

Verified SHC Patient

Thank you doctor for giving me needed information based on my questions.

Feb 2024

•

Verified SHC Patient

Thank Dr. Berry and his staff for their exceptional care during my video calls. Since the surgery, my quality of life has significantly improved, and I am forever grateful to them for their outstanding work.

Jan 2024

•

Verified SHC Patient

Dr. Berry is a fantastic Thoracic Oncologist.

Jan 2024

•

Verified SHC Patient

Dr. Berry is the best!!!! I thank G-d for him every day since my surgery!!!!!

Jan 2024

•

Verified SHC Patient

Dr. Berry seems excellent. He was clear in his explanation about my medical condition and he answered all of my questions.

Jan 2024

•

Verified SHC Patient

Excellent doctor

Jan 2024

•

Verified SHC Patient

Dr. Berry was very informative and explained everything very clearly. Had an excellent experience

Jan 2024

•

Verified SHC Patient

Excellent physician. I feel very lucky to have him as my doctor.

Jan 2024

•

Verified SHC Patient

Dr. Berry was very clear and informative, and I felt better about the whole thing after speaking to him.

Dec 2023

•

Verified SHC Patient

Dr Berry is a very knowledgeable and caring person.

Dec 2023

•

Verified SHC Patient

He is absolutely awesome! He care about well being of his patients and answer any and all relevant questions.

Nov 2023

•

Verified SHC Patient

Mark Berry åŒ»ç”ŸåŒ»æŠ€ç²¾æ¹›ã€ è®¤çœŸè´Ÿè´£ã€‚å¯¹ä»–å åˆ†ä¿¡ä»»ã€‚

Nov 2023

•

Verified SHC Patient

Knowledgeable, caring, attentive.

Nov 2023

•

Verified SHC Patient

Dr Berry is an excellent physician and I feel very fortunate to have had him assigned to my surgery and follow-up.

Nov 2023

•

Verified SHC Patient

I have found Mark to be an exceptional doctor in every respect, from his technical expertise and thoroughness,, to his empathetic, patient, and warm bedside manner. Iâ€™m very grateful that he is my physician!

Nov 2023

•

Verified SHC Patient

Dr.Berry is very knowledgeable, patient snd kind, he explained the results to my dad and me using terms we could understand, and. Presented us several options . His team will follow up with us on further diagnosis and other referral, we really enjoy having Dr Berry as my dadâ€™s thoracic surgeon. We can trust him completely. With Dr. Berryâ€™s commitment and knowledge, hope they can find the root cause of my dadâ€™s problem and get it resolved .

Nov 2023

•

Verified SHC Patient

excellent

Nov 2023

•

Verified SHC Patient

Dr. Berry has been my doctor for years. He explains things in a way I can understand. He is extremely knowledgeable and a consummate professional. He is compassionate and empathetic and is interested in the entire patient. I completely trust him to give the best possible care and always trust him to tell me everything. I am glad heâ€™s my oncology.

Nov 2023

•

Verified SHC Patient

Dr. Berry - thanks for all you continue to do for my care. I really value your expertise and guidance.

Nov 2023

•

Verified SHC Patient

Excellent knowledge base; very professional; information provided was clearly presented; choices provided; answered all questions; instills confidence. I would call him a STAR!!

Oct 2023

•

Verified SHC Patient

is good doctor

Oct 2023

•

Verified SHC Patient

Dr. Berry is a very accommodating doctor. He answered all my questions and concerns with empathy and understanding. I feel his compassion and concerns while discussing my health issues. I feel comfortable to be treated by him.

Oct 2023

•

Verified SHC Patient

He was very easy to talk to. I was able to understand all that they will be doing to help me. Iâ€™m very happy with his ability to explaining things.

Oct 2023

•

Verified SHC Patient

Very happy with Dr. Berry, He took the time needed to go over my concerns and explains everything very well.

Oct 2023

•

Verified SHC Patient

Dr. Berry is always informative and answers all questions. He is an excellent doctor, and I feel very fortunate to have my care placed with him.

Oct 2023

•

Verified SHC Patient

very nice and and listens well

Oct 2023

•

Verified SHC Patient

Dr Berry is the best!

Oct 2023

•

Verified SHC Patient

Dr.Berry is a wonderful man and physician. He listens and gives smart responses. I trust him. Who could ask for more?

Oct 2023

•

Verified SHC Patient

Iâ€™m very happy with the care l receive from Dr Berry. He is always genuine with his concerns and open and direct with his suggestions of care.

Sep 2023

•

Verified SHC Patient

He is an excellent caring surgeon and always provides top notch follow-up treatment. He is also always on time with his appointments. I would recommend him to anyone for a Thoracic Oncology surgery with complete confidence.

Sep 2023

•

Verified SHC Patient

Dr Berry is a fantastic doctor, very clear and compassionate.

Aug 2023

•

Verified SHC Patient

Dr. Berry is awesome ! He performed an Esophogectomy on me two years ago. I had Cancer. Due to his expertise and caring demeanor, I am alive and well. He continues to provide my necessary follow-up care.

Aug 2023

•

Verified SHC Patient

I am so thankful that Dr. Berry has taken care of my health needs. He is a caring excellent physician.

Aug 2023

•

Verified SHC Patient

Excellent support!

Aug 2023

•

Verified SHC Patient

What a great care team. Iâ€™m really happy with their attention to detail and how Iâ€™m doing overall, not just oncology issues.

Aug 2023

•

Verified SHC Patient

Dr. Berry was extremely thoughtful, patient and helpful.

Jul 2023

•

Verified SHC Patient

He is an amazing surgeon. Caring, compassionate and talks to you in laymanâ€™s terms so you understand what is being said. Gives excellent information and patient when asking questions that may seem repetitive. I had the best care at Stanford and was in excellent hands with Dr Berry!

Jul 2023

•

Verified SHC Patient

We had good discussion about my condition and treatment options.

Jul 2023

•

Verified SHC Patient

Very thorough and friendly in our discussion. He gave valuable options to concern going forward.

Jun 2023

•

Verified SHC Patient

HIS VISITS ARE ALWAYS ON TIME AND VERY THOROUGH.

Jun 2023

•

Verified SHC Patient

Dr Berry was very knowledgable and explained my situation very well. He gave a good explanation on my options which all made good sense. I feel very lucky to have him as my doctor. I feel less stress after talking to him.

Jun 2023

•

Verified SHC Patient

The Best!!

Jun 2023

•

Verified SHC Patient

Dr. Berry has followed my case for several years. He demonstrated that he shares my enthusiasm for a "stable outcome" from my CTs. He shows his interest in me as a patient but also as a person. I appreciate his care.

Jun 2023

•

Verified SHC Patient

Very informative

May 2023

•

Verified SHC Patient

Dr. Berry is a phenomenal physician with an amazing, caring personality. He is never in a rush and always answers questions completely. Not only a great surgeon but a wonderful human being who exudes care and concern for patients.

May 2023

•

Verified SHC Patient

Very helpful visit. Answered all of my questions.

May 2023

•

Verified SHC Patient

He is a very respectable doctor

May 2023

•

Verified SHC Patient

Excellent doctor

May 2023

•

Verified SHC Patient

Dr, Barry is fantastic, very responsible, caring and goog.

May 2023

•

Verified SHC Patient

Dr. Berry is a very good doctor answering every concern in a caring way.

May 2023

•

Verified SHC Patient

I have every confidence in Dr. Berry

Apr 2023

•

Verified SHC Patient

Dr. Berry explained to me all the possible options that can be done regarding my condition. He answered all my questions to my satisfaction.

Apr 2023

•

Verified SHC Patient

Dr. Berry is a great surgeon and a kind and thoughtful human.

Apr 2023

•

Verified SHC Patient

Dr. Berry provides clear information that allows me to participate in the process of decision making. He prepares well and listens well to patient concerns.

Apr 2023

•

Verified SHC Patient

Ideal Doctorâ€” Professional,empathetic, articulate Kind and thorough

Apr 2023

•

Verified SHC Patient

Very thorough and responsive to my questions

Mar 2023

•

Verified SHC Patient

He was very thorough and very nice. Answered all of my questions. He took time to explain my situation and possible paths forward.

Mar 2023

•

Verified SHC Patient

He was very pleasant and understanding he explained things great ðŸ˜Š

Mar 2023

•

Verified SHC Patient

Professional,articulate,,kind& thorough Thank you Doctor Berry

Feb 2023

•

Verified SHC Patient

Great surgeon, empathetic guy; straight about risks.

Feb 2023

•

Verified SHC Patient

explained everything to my satisfaction

Feb 2023

•

Verified SHC Patient

Pleasant

Feb 2023

•

Verified SHC Patient

Thank you Dr Berry. !!

Feb 2023

•

Verified SHC Patient

Dr Berry is very kind and empathetic, qualities many providers lose with time.

Jan 2023

•

Verified SHC Patient

Excellent dr great care

Jan 2023

•

Verified SHC Patient

Outstanding Doctor in every way. A pleasure to deal with and extremely helpful in his responses.

Jan 2023

•

Verified SHC Patient

Communicates very clearly and asks repeatedly if I have questions.

Jan 2023

•

Verified SHC Patient

Talking with Dr. Berry via video is almost like talking with him in the office. He is clear, direct, and thoughtful in his responses.

Dec 2022

•

Verified SHC Patient

Outstanding personality and bedside manner. For me, he was knowledgable, forthcoming and as direct as I wanted him to be. I'm blessed to have had him as my surgeon for the procedure I needed.

Dec 2022

•

Verified SHC Patient

Dr Berry is a very excellent Doctor and I am happy to have him

Dec 2022

•

Verified SHC Patient

Excellent to the point appointment

Dec 2022

•

Verified SHC Patient

Dr Berry addressed the concerns I have about ongoing CT Scans. I was satisfied with his explanation and recommendation. I feel comfortable having him direct my ongoing care.

Nov 2022

•

Verified SHC Patient

Represents the best qualities a physician could have.

Nov 2022

•

Verified SHC Patient

Ever since I first met Dr Berry in December 2019 he has been informative, concientious and very clear in his explanations. He has excellent patient skills in addition to his surgical expertise. He has always been very patient in helping me through some nerve wracking times. I am so glad I found him. When friends ask me why I traveled to Stanford, Dr Berry and the rest of the excellent staff is the reason. Thank you

Oct 2022

•

Verified SHC Patient

Dr. Berry is always very calm and caring. He takes time to listen to patients narration and shows interests in disease or health conditions the patient has but not in his field. This demonstrates he takes a holistic view of understanding and caring patient's health and medical treatments.

Oct 2022

•

Verified SHC Patient

I did not feel rushed with Dr. Berry. He answered all our questions with patience and care. We also liked his nurse, JoAnne.

Oct 2022

•

Verified SHC Patient

Very impressed with the interactions with the entire team.

Oct 2022

•

Verified SHC Patient

Dr. Berry is easy to work with on teleconference calls. He listens and answers all questions. Doesnâ€™t make you feel like you have to rush through the call. Experience has always been excellent.

Oct 2022

•

Verified SHC Patient

He is an exceptional doctor!

Oct 2022

•

Verified SHC Patient

He is amazing

Oct 2022

•

Verified SHC Patient

Very thorough and patient. Did not rush the call. Always a pleasure.

Oct 2022

•

Verified SHC Patient

Dr Berry is amazing

Sep 2022

•

Verified SHC Patient

Dr Berry was organized in presenting the information for the proposed procedure. He answered all the questions we had. He even drew a diagram to explain the extent of the procedure.

Sep 2022

•

Verified SHC Patient

Dr. Berry was attentive, kind, professional, knowledgeable and seemed genuinely concerned about my having the best possible outcome to my problem.

Sep 2022

•

Verified SHC Patient

Asked relevant questions answered all of mine.

Sep 2022

•

Verified SHC Patient

Explained everything well.

Sep 2022

•

Verified SHC Patient

Dr Berry was very good at presenting and answering my questions.

Aug 2022

•

Verified SHC Patient

Straightforward, considerate, and pleasant. Was highly recommended to me. Thanks, Dr. Berry.

Aug 2022

•

Verified SHC Patient

an excellent visit - THANKS

Aug 2022

•

Verified SHC Patient

Wonderful physician. Unlike the stereotype of a typical surgeon, Dr. Berry never rushes his appointments and ensures that he provides as much time as is needed!

Aug 2022

•

Verified SHC Patient

I really enjoy Dr Berry and I find him very helpful and personable. Great physician.

Jul 2022

•

Verified SHC Patient

Dr Berry was very kind and patient with my long list questions! Iâ€™m very thankful.

Jul 2022

•

Verified SHC Patient

Have always had an extraordinary visit with great service and attention to my questions.

Jul 2022

•

Verified SHC Patient

He was excellent.

Jul 2022

•

Verified SHC Patient

very straight forward and informative , answered all my questions , made it very clear to me what to expect and what to hope for .

Jun 2022

•

Verified SHC Patient

Outstanding surgeon and physician. I can tell he really cares about me; I imagine he demonstrates this care with all his patients.

Jun 2022

•

Verified SHC Patient

a real GEM!!

Jun 2022

•

Verified SHC Patient

Dr Mark Berry was great at explaining everything and anticipating my questions and concerns. I felt he is very versed in this type of medicine. I was very comfortable talking to him about the procedures and complications that could arise. He made me feel at ease about what's ahead. Thank you, Dr Berry.

Jun 2022

•

Verified SHC Patient

Dr. Berry provides clear, consistent, and thoughtful information. I count on his medical expertise and his ability to assess multiple physical issues that may affect my lungs.

Jun 2022

•

Verified SHC Patient

Always a great experience. Professional, caring staff.

Jun 2022

•

Verified SHC Patient

Excellent!

Jun 2022

•

Verified SHC Patient

Dr. Berry was very clear and to the point. He took time to explain everything in detail.

May 2022

•

Verified SHC Patient

Dr Berry is excellent!

May 2022

•

Verified SHC Patient

Seemed like a reasonable & capable physician to me.

May 2022

•

Verified SHC Patient

Very professional and pleasant

May 2022

•

Verified SHC Patient

Very compassionate and pleasing to talk to.

May 2022

•

Verified SHC Patient

Very competent

May 2022

•

Verified SHC Patient

Dr. Berry is very easy to talk with and he is very attentive to what I have to say. I have very good feeling about him and his care team.

May 2022

•

Verified SHC Patient

I appreciate that he looked at my records before talking with me. Made me feel like he was interested in me as a patient and what to do next.

May 2022

•

Verified SHC Patient

He was very good at explaining both my medical issue and the various treatment options. He was very thorough explaining the operation I will have, along with any possible dangers, recovery time, etc. and long term follow up.

May 2022

•

Verified SHC Patient

Dr. Berry seemed sincerely concerned about my problem and is referring me to Dr. Hovsepian ASAP.

Apr 2022

•

Verified SHC Patient

Excellent Dr.

Apr 2022

•

Verified SHC Patient

Dr Berry is an outstanding physician and makes me confidently feel that I am being cared for.

Apr 2022

•

Verified SHC Patient

This was an in person visit and Everything went very well.

Apr 2022

•

Verified SHC Patient

Great MD

Apr 2022

•

Verified SHC Patient

He was very thorough and took a lot of time to thoroughly answer all my questions

Apr 2022

•

Verified SHC Patient

He comes across as really knowing his job and not talking over your head.

Apr 2022

•

Verified SHC Patient

Mark Berry is a wonderful Surgeon and talks to you in terms that one understand stands not in the medical field. I feel like I am in great hands!

Apr 2022

•

Verified SHC Patient

DeBerry was thorough and knowledgeable.

Apr 2022

•

Verified SHC Patient

Stellar care & communication! Very appreciated!

Apr 2022

•

Verified SHC Patient

Dr. Berry is wonderful.

Mar 2022

•

Verified SHC Patient

We were very impressed with Dr. Berry. He was very informative and answered all of our questions. He also showed us empathy which we did not receive with our prior service provider. It was nice to have a Dr. give us some hope rather than suggest palliative care.

Mar 2022

•

Verified SHC Patient

Thank for pay attention all the details on all the questions

Mar 2022

•

Verified SHC Patient

Terrific surgeon. Thos will be my second operation with him.

Mar 2022

•

Verified SHC Patient

Dr. Berry is the best!!

Mar 2022

•

Verified SHC Patient

Dr.Berry was extremely professional and pleasant throughout the consultation. All questions were answered to their utmost and at no point did we feel rushed. So happy to have had this consultation!

Mar 2022

•

Verified SHC Patient

I am very appreciative to be seen and taken care of by Dr. Berry and his staff. Looking forward to meeting the other doctors who will be part of Dr. Berry's team for my procedure.

Mar 2022

•

Verified SHC Patient

Excellent Dr. Mark Berry

Mar 2022

•

Verified SHC Patient

I thought he took time to answer all my questions and explain my situation

Mar 2022

•

Verified SHC Patient

Very professional, well spoken and easy to communicate with.

Feb 2022

•

Verified SHC Patient

It is easy to get references, or suggestions about a doctor. And dont get this wrong Dr. Berry is very highly recommended. After meeting him and talking to him about the surgery he gave me confidence this is difficult. My wife and I have 110% confidence that he knows and can do what is right. This is most important to both of us.

Feb 2022

•

Verified SHC Patient

Mark Berry is a very thorough and personable doctor who explains things really well and simply. Iâ€™m very pleased to have Dr. Berry on my care team at Stanford.

Feb 2022

•

Verified SHC Patient

Dr Berry is The Best !! He is So very Amazing !

Feb 2022

•

Verified SHC Patient

Kind, knowledgeable and makes me feel better.

Feb 2022

•

Verified SHC Patient

He is an excellent communicator and I feel fortunate to have his as my surgeon for the procedure I am about to have.

Feb 2022

•

Verified SHC Patient

Thank you Dr. Berry for all you do for your patients.

Feb 2022

•

Verified SHC Patient

Dr. Berry is outstanding and has an empathetic understanding of my concerns. He also helped explain some of the intrinsic detail of my surgery so I could better understand the healing process. I feel very fortunate to have had his expertise, skill and experience for my procedure.

Feb 2022

•

Verified SHC Patient

Great Doc...

Jan 2022

•

Verified SHC Patient

Good communicator.

Jan 2022

•

Verified SHC Patient

I had an excellent experience with Dr. Berry.

Jan 2022

•

Verified SHC Patient

He was thorough and answered all my questions.

Jan 2022

•

Verified SHC Patient

Very helpful definition of problem, options and plan.

Jan 2022

•

Verified SHC Patient

Dr Berry was personable, answered questions, knowledgeable. Seemed great. Our call dropped and a little rough audio on his end initially but not a big problem, Handled promptly.

Jan 2022

•

Verified SHC Patient

He was friendly, professional and took time to answer any questions I had. I felt comfortable with him.

Jan 2022

•

Verified SHC Patient

Appreciated expertise, thoroughness, professionalism, responsiveness, compassion, generous time allotment for questions.

Jan 2022

•

Verified SHC Patient

Thank you so much, Dr. Berry!

Jan 2022

•

Verified SHC Patient

Mark Berry is an excellent surgeon and very kind man. I feel very lucky to have had him as my surgeon.

Jan 2022

•

Verified SHC Patient

Mark Berry is an outstanding communicator who answered all of our questions and instilled confidence.

Dec 2021

•

Verified SHC Patient

Dr.Berry was clear in his presentation and provided the information that I needed. He was pleasant and easy to talk to.

Dec 2021

•

Verified SHC Patient

Dr. Berry and his staff were an excellent care team. I hope I never have to do so, but I would recommend him highly to anyone looking for a surgeon or a cancer care team.

Dec 2021

•

Verified SHC Patient

Excellent to be with you.

Dec 2021

•

Verified SHC Patient

What a wonderful man and doctor! He took his time, answered all our questions, drew excellent diagrams, and left us feeling confident about having surgery with him.

Dec 2021

•

Verified SHC Patient

I like interacting with him regarding my medical issues. He covers every question I have.

Dec 2021

•

Verified SHC Patient

Very thorough, explained everything really well. Answered all my questions, was very patient. Seemed very knowledgeable about the situation of my surgery needed. Which makes me feel very comfortable About the surgery coming up soon.

Dec 2021

•

Verified SHC Patient

Iâ€™m very confident under his care.

Nov 2021

•

Verified SHC Patient

Thank you, Thank you Thank you Dr Berry!

Nov 2021

•

Verified SHC Patient

Well prepared and attentive. I would recommend him highly to future patients.

Nov 2021

•

Verified SHC Patient

He was very thorough.

Nov 2021

•

Verified SHC Patient

Dr Berry will refer to Urologist

Oct 2021

•

Verified SHC Patient

Excellent

Oct 2021

•

Verified SHC Patient

Dr. Berry is by far the best doctor I have had.

Oct 2021

•

Verified SHC Patient

Dr Barry is a great surgeon My mother is a senior in her 90â€™s and itâ€™s very confusing the new technology.

Oct 2021

•

Verified SHC Patient

Excellent

Oct 2021

•

Verified SHC Patient

Great doctor and answers all questions

Oct 2021

•

Verified SHC Patient

Dr. Berry performed exceptionally well in every aspect of my needs. He studied my tumor and prepared me for risks in its removal. Dr. Berry and his team gave me much confidence and the best possible outcoming any patient could have hoped for. An outstanding example of quality care. Thank you.

Sep 2021

•

Verified SHC Patient

perfect

Sep 2021

•

Verified SHC Patient

I feel very comfortable under Mark Berry's care and am prepared for upcoming surgery.

Sep 2021

•

Verified SHC Patient

It was so wonderful seeing Dr. Berry! He is a thorough and concerned physician. I am so grateful that he is taking care of my healthcare needs. He is a very knowledgeable and kind Doctor.

Sep 2021

•

Verified SHC Patient

Dr. Mark Berry is an excellent Doctor! And his team is an excellent team!

Sep 2021

•

Verified SHC Patient

I was very impressed with his knowledge and his bedside manner.

Sep 2021

•

Verified SHC Patient

Patient, caring, dedicated and easy to communicate with.

Aug 2021

•

Verified SHC Patient

The best! I am in great hands! Thank You

Aug 2021

•

Verified SHC Patient

He was professional and answered all questions. Seemed to be empathetic of the situation and seems to genuinely care for his patients.

Aug 2021

•

Verified SHC Patient

Excellent !

Aug 2021

•

Verified SHC Patient

Dr. Berry's bio was impressive in that he had a broad range of experiences, including Engineering interests at Pennsylvania University. My video visit with Dr. Berry was excellent. A skilled surgeon with these added talents is exactly the right fit for me. He discussed the task at hand in a clear, reasoned manner, thorough in scope, covering the process and range of outcome possibilities. I left the visit confident that I was in skilled hands and lucky to have made this connection with such an excellent surgeon.

Aug 2021

•

Verified SHC Patient

Excellent patient care and concern provided by Dr Berry. As always, he provided ample time for my questions and very thoughtful with his response.

Aug 2021

•

Verified SHC Patient

Dr Berry has a very calm manner. He answered all my questions very precisely and he was very understanding as to my lack of knowledge concerning my health issues.

Aug 2021

•

Verified SHC Patient

Excellent doctor with great bed side manner.

Aug 2021

•

Verified SHC Patient

He's a superstar!!

Aug 2021

•

Verified SHC Patient

Dr Berry is A Fantastic Doctor- I feel So very Blessed to be in his care ðŸ™

Aug 2021

•

Verified SHC Patient

I'm very happy with Dr. Berrys treatment and attention to detail about me and my treatment.

Jul 2021

•

Verified SHC Patient

I appreciate Dr. Berry keeping my appointment on time and patiently answered all my questions. He has excellent bedside manner and one of the best doctors I have in Stanford hospital. I will highly recommend him.

Jul 2021

•

Verified SHC Patient

He is a very excellent doctor he ask the right questions and has good answers to all of my questions.

Jul 2021

•

Verified SHC Patient

He is fantastic!

Jul 2021

•

Verified SHC Patient

I continue to think quite highly of Dr. Berry and his staff

Jul 2021

•

Verified SHC Patient

Thank you Dr. Mark Berry for your clear and concise explanations.

Jul 2021

•

Verified SHC Patient

Good informative visit with Dr. Berry. His response was concise and to the point. Impression was knowledgeable and caring from a conservative approach.

Jul 2021

•

Verified SHC Patient

He and his entire staff are the most amazing group that I could possibly hope for. The are kind, compassionate and really listen and make me feel that they are invested in my well being. You should be proud to have all of them representing Stanford Health Care.

Jun 2021

•

Verified SHC Patient

Dr. Berry is an excellent doctor. I am very satisfy.

Jun 2021

•

Verified SHC Patient

Dr. Berry was the first doctor to give me any hope that a solution to my health problem was possible. All my other doctors have pretty much said that a surgical resection was not feasible and that palliative chemo was all I could look forward to.

Jun 2021

•

Verified SHC Patient

I liked him very much.

Jun 2021

•

Verified SHC Patient

He is fantastic and saved my life!

Jun 2021

•

Verified SHC Patient

Dr. Berry is a very supportive, concerned physician. i am very grateful that he is my oncologist.

Jun 2021

•

Verified SHC Patient

Wonderful doctor, kind and caring. He has empathy and compassion.

Jun 2021

•

Verified SHC Patient

Very caring and knowledgeable!

May 2021

•

Verified SHC Patient

An excellent doctor and so understanding. Just a wonderful person.

May 2021

•

Verified SHC Patient

Heâ€™s great.

May 2021

•

Verified SHC Patient

I find Dr.Berry to be an honest and thorough communicator. I wouldn't hesitate to recommend him to anyone who has a problem similar to the one I encountered. Should my condition worsen in the future, I would hope to be able to contact him again for assistance.

May 2021

•

Verified SHC Patient

I liked him a lot. He listened and he seemed well informed about my medical history. He explained things so that I understood what he was talking about.

May 2021

•

Verified SHC Patient

Excellent doctor, patiently explained everything with details.

May 2021

•

Verified SHC Patient

Excellent doctor! Answered all my questions clearly and I left feeling extremely confident that no further visits were needed.

Apr 2021

•

Verified SHC Patient

He is just a wonderful and amazing surgeon. Always answers questions and explains them in terms one can understand!

Apr 2021

•

Verified SHC Patient

Easy to understand and follow. Very knowledgeable and caring.

Apr 2021

•

Verified SHC Patient

I appreciate him taking the extra time to explain everything and making sure I understood the upcoming procedure.

Apr 2021

•

Verified SHC Patient

Kind, empathetic, trust him completely!

Apr 2021

•

Verified SHC Patient

Very patient, calm demeanor. Makes patient feel at ease. I felt cared for. He is a fantastic person and surgeon.

Apr 2021

•

Verified SHC Patient

Excellent

Apr 2021

•

Verified SHC Patient

FABULOUS!!

Apr 2021

•

Verified SHC Patient

Excellent surgeon.

Feb 2021

•

Verified SHC Patient

Nice friendly nurses!

Nov 2020

•

Verified SHC Patient

Very patient listener. Dr. Berry took his time to explain everything and never felt he was in a rush. Very attentive.

Jun 2020

•

Verified SHC Patient

Dr. Berry is the best!

Apr 2020

•

Verified SHC Patient

I continue to be favorably impressed by this team, and grateful for Dr. Berry! Skill in robotic surgery.

Jan 2020

•

Verified SHC Patient

Very good, always answered questions.

Jan 2020

•

Verified SHC Patient

Amazing DOCTOR amazing N.P.

Jan 2020

•

Verified SHC Patient

I appreciate Dr. Berry very much. He understands my fear and calms me down as much as he can.

Dec 2019

•

Verified SHC Patient

Dr. Berry was the best doctor along with outer doctors I had treatment or operations at Stanford.

Sep 2019

•

Verified SHC Patient

Dr. PA, NA were awesome!

Aug 2019

•

Verified SHC Patient

Excellent care: kind, concerned, thorough, expert.

Aug 2019

•

Verified SHC Patient

Dr. Berry & staff were very professional, knowledgeable & a pleasure to interact with during my visit.

Jul 2019

•

Verified SHC Patient

Trusted my life & will continue to do so. Very grateful for care given to me.

Jul 2019

•

Verified SHC Patient

Dr. Berry spent so much time with us & answered all questions & concerns that we had.

May 2019

•

Verified SHC Patient

Showing care to patient very excellent. Care to patient's family as well.

May 2019

•

Verified SHC Patient

Stanford has the best.

Apr 2019

•

Verified SHC Patient

Mark Berry is a uniquely empathetic physician. I have already recommended him twice. I feel extremely fortunate to have him and the Stanford staff as my care providers.

Apr 2019

•

Verified SHC Patient

Absolutely have & had faith in Dr. Berry.

Apr 2019

•

Verified SHC Patient

Dr. Berry demonstrated outstanding professionalism and care as a surgeon and confidence. He had our trust from our first visit.

Mar 2019

•

Verified SHC Patient

Great experience 10.

Feb 2019

•

Verified SHC Patient

Dr. Berry is excellent as is his team.

Jan 2019

•

Verified SHC Patient

I like Stanford, I will share that this is a good place.

Jan 2019

•

Verified SHC Patient

Both the dr. and the PA were extremely helpful and patient with my questions. They were very professional and worked well together.

Dec 2018

•

Verified SHC Patient

Other than being so very late, Dr. Berry is great.

Nov 2018

•

Verified SHC Patient

it was good experience with care provider.

Oct 2018

•

Verified SHC Patient

This was an excellent visit w/Dr. Berry and his nurse! Great explanation AND reassurance of the future course of action.

Sep 2018

•

Verified SHC Patient

Very good!

Sep 2018

•

Verified SHC Patient

Dr. Berry always answers all my questions and he is a friendly, caring dr.

Aug 2018

•

Verified SHC Patient

Per usual the doctors, nurses - staff & the Stanford Cancer Center made me feel like I was their only patient that day.

Aug 2018

•

Verified SHC Patient

Dr. Berry is an excellent doctor and a truly nice person.

Aug 2018

•

Verified SHC Patient

Very good.

Aug 2018

•

Verified SHC Patient

Very good!

Jul 2018

•

Verified SHC Patient

Dr. Berry was very informative and organized. We were very impressed.

Jul 2018

•

Verified SHC Patient

Dr. Berry is excellent.

Jul 2018

•

Verified SHC Patient

Excellent responses to our concerns & questions.

May 2018

•

Verified SHC Patient

I have complete confidence in Dr. Berry.

Apr 2018

•

Verified SHC Patient

Very professional surgeon. Took his time with me. Explaining things in terms I could easily understand. I appreciated his calm and reassuring manner.

Apr 2018

•

Verified SHC Patient

Good.

Mar 2018

•

Verified SHC Patient

I had major decisions to make regarding surgery and my team was very helpful.

Dec 2017

•

Verified SHC Patient

All are very good.

Nov 2017

•

Verified SHC Patient

I always feel I can take as much time as needed - they do not rush you through.

Nov 2017

•

Verified SHC Patient

My experience during my visit with care provider was good.

Aug 2017

•

Verified SHC Patient

Dr. Berry & his team are excellent! He is very compassionate and really listens to his patients and takes his time to address all concerns and questions. Very professional & highly recommend!

Jul 2017

•

Verified SHC Patient

Dr. Berry is an INCREDIBLE physician; I would recommend him with no reservations to anyone who suffered from a thoracic tumor; no one could have removed my tumor with more skill. than Dr. Berry. His concern for the process of removing the tumor was remarkable - since he wanted to listen to my concerns and did not want to use a procedure that I was opposed to - although an _____ of doctors whom I had seen prior to Dr. Berry did not hold that same concern.

Jul 2017

•

Verified SHC Patient

I was very comfortable in the knowledge that I was being treated as they would treat a family member.

Jun 2017

•

Verified SHC Patient

Dr. Berry is an amazing dr. and helped us through a difficult time.

Mar 2017

•

Verified SHC Patient

Exceptionally competent.

Jan 2017

•

Verified SHC Patient

Worth the wait - Stanford is worth it.

Dec 2016

•

Verified SHC Patient

Dr. Berry is always patient, concerned and never rushed.

Oct 2016

•

Verified SHC Patient

Excellent information.

Aug 2016

•

Verified SHC Patient

Both Dr. Berry and his PA were informed, knowledgeable, focused, and pleasant.

Jul 2016

•

Verified SHC Patient

This was annual follow-up check up so some above questions not applicable we think very highly of Dr. Berry and his staff.

Jul 2016

•

Verified SHC Patient

Dr. Berry has a most comfortable and confidence inspiring manner by being most unassuming and down to earth. And a bit shy.

May 2016

•

Verified SHC Patient

Dr. Berry fully explained what my surgery would entail and he answered every question of which there were many, fully. I have every confidence in Dr. Berry doing my surgery.

Apr 2016

•

Verified SHC Patient

Doctors - at thoracic unit cancer center center - excellent!

Apr 2016

•

Verified SHC Patient

Dr. Berry & his team were so professional but caring & reassuring.

Mar 2016

•

Verified SHC Patient

Care provider was highly recommended and this proved to be correct.

Mar 2016

•

Verified SHC Patient

Dr. Berry explained things to me about my condition in detail. He showed me my tumor and even drew a diagram for me so I could better understand. He took extra time with me to explain and didn't make me feel rushed.

Mar 2016

•

Verified SHC Patient

I felt my case was not completely researched.

Mar 2016

•

Verified SHC Patient

We were very impressed with your health care.

Mar 2016

•

Verified SHC Patient

Everything was well explained.

Mar 2016

•

Verified SHC Patient

I learned much more than expected!

Feb 2016

•

Verified SHC Patient

Dr. Berry's team is great!

Jan 2016

•

Verified SHC Patient

Dr. Berry is wonderful - Explains so that you can understands - Lets you ask questions without feeling rushed.

Nov 2015

•

Verified SHC Patient

He is exceptional.

Sep 2015

•

Verified SHC Patient

The entire staff, doctors, nurses, assistants, and entire hosp./clinic staff treated me like their only patient.

Aug 2015

•

Verified SHC Patient

My direct experiences with this team have been quality.

Jul 2015

•

Verified SHC Patient

Total confidence in DR. Berry and N.P. Alfredo DeJesus. The best possible patient care & compassion.

Jul 2015

•

Verified SHC Patient

I have complete confidence in Dr Berry. He teats you like a person,not another number.

May 2015

•

Verified SHC Patient

Personable and buttoned-down. Great

May 2015

•

Verified SHC Patient

My experiences with Dr. Berry were very positive. He always made me feel like he truly cared about me and what I was going through. His team was fantastic, too.

Apr 2015

•

Verified SHC Patient

I can't say enough good about Dr. Berry, NP Alfredo De Jesus and support staff. They take the best care of me. My condition is complex and unique. They are considerate and supportive and help me feel safe and well cared for.

Mar 2015

•

Verified SHC Patient

I have every confidence in Dr. Barry. He is the best.

Mar 2015

•

Verified SHC Patient

Dr. Berry was very helpful and kind! Highly recommend him and his staff!

Mar 2015

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Mark Francis Berry, MD

Thoracic surgeon, Surgical oncologist, Thoracic specialist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Publications

Clinical Trials

Specializing In

Practice Locations

Thoracic Surgery Clinic in Palo Alto Palo Alto, CA

Thoracic Surgery Clinic in Palo Alto

Thoracic Cancer Program in Palo Alto Palo Alto, CA

Thoracic Cancer Program in Palo Alto

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

Esophagus Center Redwood City, CA

Esophagus Center

Chest Wall Surgery Program Palo Alto, CA

Chest Wall Surgery Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(330 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Mark Francis Berry, MD

Thoracic surgeon, Surgical oncologist, Thoracic specialist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Publications

Clinical Trials

Specializing In

Practice Locations

Thoracic Surgery Clinic in Palo Alto Palo Alto, CA

Thoracic Surgery Clinic in Palo Alto

Thoracic Cancer Program in Palo Alto Palo Alto, CA

Thoracic Cancer Program in Palo Alto

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

Esophagus Center Redwood City, CA

Esophagus Center

Chest Wall Surgery Program Palo Alto, CA

Chest Wall Surgery Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(330 reviews)

Referring Physicians

PHYSICIAN HELPLINE